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Foreword
For the ideal of a Republic of Opportunity to be meaningful, it must apply to all. 
Treating substance abuse and drug addiction as a public health issue, rather than 
as a criminal justice issue, helps individuals, helps families, and helps communities. 
It reduces crime because it rebuilds lives. So it helps all of us.
Ireland has a problem with substance misuse. Rates of drug use in Ireland have risen 
significantly over the past decade, with the greatest increases among younger people. 
Many Irish people engage in harmful drinking patterns and alcohol has become a major 
drugs issue. The rise in the number of families affected by the loss of a loved one due 
to drug use is a serious cause for concern. These issues highlight the need to intervene 
effectively to reduce the harms associated with substance misuse, and combat the 
underlying reasons for the demand for drugs.
Reducing Harm, Supporting Recovery represents a whole-of-government response 
to the problem of drug and alcohol use in Ireland. The strategy draws upon a range 
of government policy frameworks in order to reduce the risk factors for substance 
misuse, such as social or educational disadvantage, family circumstances or poor 
health. It recognises the importance of supporting the participation of communities 
in key decision making structures, so that their experience and knowledge informs the 
development of solutions to solve problems related to substance misuse in their areas.
Reducing Harm, Supporting Recovery emphasises a health-led response to drug 
and alcohol use in Ireland, based on providing person-centred services that promote 
rehabilitation and recovery. A person-centred approach means giving people a say 
in their own treatment and supporting them to play a role in their own recovery. This 
approach also requires services to work together so that people do not fall through 
the cracks, as they navigate the different services required to meet their specific needs.
The strategy recognises the need for a balanced approach, which involves reducing 
the demand for drugs and reducing access to illegal drugs. It outlines the key law 
enforcement strategies to protect the public from the harms of illegal drug markets 
and the monitoring arrangements required to meet Ireland’s international obligations 
at EU and UN level.
I welcome the initiative of the Minister for Health, Simon Harris TD and the Minister 
of State for Health Promotion and the National Drugs Strategy, Catherine Byrne TD, 
for bringing forward this strategy to respond to the problem of drug and alcohol use 
in Ireland.
This government will work to build a Republic of Opportunity that means something 
in people’s lives, especially those who have not had many opportunities in the past. 
I hope the new strategy will make a real difference and encourage everyone to put 
their own health and wellbeing first, so that we can realise the vision of this strategy 
for a healthier and safer Ireland.
Leo Varadkar, T.D. 
Taoiseach
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Foreword
As Minister I firmly believe in a health-led and person-centred approach to our 
drug and alcohol problem. Following my recent appointment as Minister of State 
for Health Promotion and the National Drugs Strategy, my ministerial remit has 
been extended to include the Healthy Ireland Framework. Alcohol and drug policy 
are now core elements of my portfolio in line with the central vision of Reducing 
Harm, Supporting Recovery, a health-led response to drug and alcohol use in 
Ireland.
Through my involvement in the public consultation for this strategy, I heard how 
drug and alcohol use affects individuals, families and communities across the 
country and what key issues should be addressed in the new response. The need 
for a more compassionate approach to drug use was raised repeatedly in the 
course of the consultation, with many people calling for drug use to be treated as a 
health issue, rather than a criminal issue. I was also struck by the fact that so many 
contributors to the public consultation believed that drug and alcohol education 
needs to start in primary school and continue through secondary school.
The importance of high quality drug and alcohol education is recognised in the 
strategy, which recommends that substance use education should be provided 
alongside wellbeing programmes, information campaigns and other preventative 
measures. Together these initiatives, if effectively delivered, give young people 
the tools to make informed choices about substance use and encourage them to 
embrace positive lifestyle changes, which can improve their health and wellbeing.
The independent expert panel, that conducted a review of our previous drug 
strategy, characterised alcohol as the elephant in the room, in considering Ireland’s 
response to the drug problem. This strategy acknowledges that alcohol, while legal, 
is a drug like any other and prioritises an integrated public health approach to drug 
and alcohol use. I hope this approach will be strengthened in the coming years. The 
strategy contains many measures which should contribute towards a reduction 
in alcohol-related harm and delay early alcohol use among young people. The 
Public Health (Alcohol) Bill which is currently being progressed, contains legislative 
provisions to reduce alcohol consumption in Ireland, and this will also be a key step 
forward.
A lot of work has been done over the past two decades to develop comprehensive 
drug and alcohol services that are capable of dealing with all substances. There 
is still considerable scope for improvement. That’s why this strategy contains 
a series of actions which aim to reduce waiting times, provide more equity of 
access to services around the country and remove potential barriers to accessing 
treatment by those with complex needs. The introduction of a pilot supervised 
injecting facility in Dublin’s city centre and the establishment of a working group to 
examine alternative approaches to the possession of controlled drugs for personal 
use, are among a number of initiatives contained within the strategy to promote a 
harm reducing and rehabilitative approach to drug use.
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The strategy also highlights the importance of continuing support for law 
enforcement in an effort to combat organised crime groups which traffic illegal 
drugs into Ireland. The importance of monitoring changing illegal drug markets, 
against the background of national, EU and broader international experience and 
best practice, is also emphasised in the strategy. Drug-related intimidation is a 
further area of concern addressed in the strategy which I believe requires special 
attention, as it presents a real threat to public safety in communities.
Finally, I would like to thank the many people who have been involved in the 
development of this strategy and have been working intensively on this process 
since December 2015. I would particularly like to thank John Carr, for his able 
stewardship of the Steering Committee on the National Drugs Strategy. I would 
like to pay a special tribute to the service users and recovery champions who 
addressed the public consultation events in Dublin, Limerick, Cork, Galway, 
Kilkenny and Carrick-on-Shannon. They demonstrated that with the support and 
help of their families, communities and the staff of the drug and alcohol services, 
people can rebuild their lives after addiction and that recovery is an attainable goal.
Catherine Byrne, T.D. 
Minister of State for Health Promotion and the National Drugs Strategy
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CHAPTER 1 – Introduction
Reducing Harm, Supporting Recovery  sets out the Government’s strategy to address the 
harm caused by substance misuse in our society up to 2025.  It identifies a set of key actions 
to be delivered between 2017 and 2020, and provides an opportunity for the development of 
further actions from 2021 to 2025 to address needs that may emerge later on in the lifetime 
of the strategy.
The strategy aims to provide an integrated public health approach to substance misuse. 
Substance misuse means the harmful or hazardous use of psychoactive substances, including 
alcohol, illegal drugs and the abuse of prescription medicines. The public consultation which 
informed the strategy highlighted changing attitudes towards people who use drugs, with calls 
for drug use to be treated first and foremost as a health issue.
Ireland’s previous national drugs strategies covered the period from 2001 to 2008 1 and 2009 
to 2016 2 respectively. Both strategies aimed to reduce the harm caused by the misuse of 
drugs, through a concerted focus on supply reduction, prevention, treatment, rehabilitation 
and research. The new strategy will also advocate a harm reduction approach, but will place 
a greater emphasis on supporting a health-led response to drug and alcohol use in Ireland.
Partnership between the statutory, community and voluntary sectors was a major factor in the 
success of previous strategies, and will continue to be the cornerstone of the new strategy. Drug 
and Alcohol Task Forces (DATFs) will play a key role in coordinating interagency action at local 
level and supporting evidence-based approaches to problem substance use, including alcohol 
and illegal drugs. The new strategy will provide a way of measuring the collective response to 
the drug problem, through a performance measurement framework.
The Healthy Ireland Framework 3 provides an over-arching context for the development of this 
new strategy and its actions will contribute towards improving the health, wellbeing and safety 
of the population of Ireland in the coming years. The new strategy will foster a person-centred 
approach to those who develop drug or alcohol-related problems, while underlining the need 
for a whole-of-Government response to the socio-economic, cultural and environmental risk 
factors contributing to the causes of substance misuse.
This Chapter sets out the context for the strategy and outlines the vision for the future. 
Chapter 2 describes the vision, values and goals linked to the overall strategic vision.
The five key goals set out to realise the vision are discussed in Chapters 3, 4, 5, 6 and 7. Chapter 
3 outlines the work underway to promote and protect health and wellbeing related to substance 
misuse, and proposes some specific actions to strengthen the response in this area. Chapter 
4 describes the measures that have been undertaken to minimise the harm caused by the 
use and misuse of substances and promote rehabilitation and recovery, and proposes a range 
of new measures to improve health and social outcomes for people affected by substance 
misuse. Chapter 5 discusses the key measures being undertaken to address the harms of drug 
markets and reduce access to drugs for harmful use. Chapter 6 examines the arrangements in 
place to support the participation of individuals, families and communities in the development 
of solutions to respond to the drug problem and to provide safe, person-centred services. 
Chapter 7 considers the evidence needed to inform the development of policy, initiatives and 
interventions to address problem substance use.
Chapter 8 outlines the arrangements required to support the effective implementation of 
the strategy, including the structures through which this will be done. It also describes the 
performance measurement system which will be used to measure the collective response to 
the drug problem. Chapter 9 sets out the key conclusions from the strategy, which will inform 
the policy direction to the drug problem in future years. The strategic action plan for the period 
2017-2020 is outlined in Chapter 10.
7Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
Vision
Our vision is for:
 “A healthier and safer Ireland, where public health and safety is protected and the harms 
caused to individuals, families and communities by substance misuse are reduced and 
every person affected by substance use is empowered to improve their health and 
wellbeing and quality of life”.
To realise this vision, five strategic goals have been identified:
1. Promote and protect health and wellbeing.
2. Minimise the harms caused by the use and misuse of substances and promote 
rehabilitation and recovery.
3. Address the harms of drug markets and reduce access to drugs for harmful use.
4. Support participation of individuals, families and communities.
5. Develop sound and comprehensive evidence-informed policies and actions.
Context
Since the first drugs strategy was introduced in 2001 1, much has been done to improve access 
to treatment and provide a wider range of services for those who develop health problems as 
a result of the consumption of alcohol and other drugs. Methadone maintenance treatment has 
become more widely available, particularly in inner city areas, and in those parts of the country 
with higher rates of heroin use. Local and Regional Drug and Alcohol Task Forces (DATFs) have 
supported the development and expansion of integrated and accessible community-based 
services. This has resulted in greater access at local level to harm reduction initiatives, such as 
methadone and needle exchange and other wrap-around services and supports, such as advice 
and information, family support, childcare and complementary therapies.
In cooperation with family support networks, community and voluntary-led providers and peer 
networks, the Health Service Executive (HSE) has provided training in the administration of 
the opioid anti-dote naloxone to reduce the incidence of fatal overdoses among people who 
inject drugs 4. Additional HSE funding has also resulted in an increased number of residential 
addiction beds providing treatment, detoxification and aftercare services. However, it is 
acknowledged that there is a need to provide wider geographic access to addiction services 
and to continue to diversify the range of treatment options available to meet current and 
emerging needs.
Significant law enforcement efforts have been invested in intercepting drugs destined for 
the Irish market. International operations spearheaded by law enforcement agencies have 
resulted in significant seizures and the disruption of organised crime networks involved in the 
importation, distribution and sale of illegal drugs in this country. Recent years have also seen a 
decisive response to the proliferation of headshops selling new psychoactive substances across 
the country. Legislation preventing the sale of psychoactive substances in headshops has been 
introduced and new controls have been put in place to remove these harmful substances from 
our streets 5. However, drugs continue to be widely and easily accessible and the range of 
methods by which drugs can be sourced has expanded significantly in recent years, in particular 
through the internet. In tandem with this, escalating levels of violence related to the drugs trade 
have had a serious impact in a number of communities.
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While communities experiencing large-scale social and economic deprivation and 
marginalisation continue to be disproportionately affected by drugs issues, the impact of the 
drug problem has extended across the country into other cities, towns and rural areas over 
the course of the last two decades. The nature of problem drug use has also changed; a wide 
range of drugs are now being used, including legal drugs, illegal drugs and alcohol. The illicit 
trade in prescribed medications, such as benzodiazepines and z-drugs, has created a serious 
threat to public health, particularly among the population of people who are homeless and use 
substances.
Substance misuse affects people from all walks of life, from different backgrounds and 
communities. The 2014/15 drugs prevalence survey 6 found that one in four Irish adults (26.4%) 
has tried an illegal drug at least once in their lifetime. Trends over the past decade point to 
an increase in the rate of last year (an indicator of recent use) and last month (an indicator 
of current use) drug use, with the greatest increases in drug use amongst younger people. In 
common with other European countries, the use of cannabis is considerably higher than any 
other form of drug, with 6.5% of adults using this drug in the last year. Younger people are 
more likely to use cannabis than older adults. In relation to illegal drug use, cannabis is the 
most commonly used drug among children in the 15-16 year age group.
A recent study indicates that the prevalence of problematic opiate use in Ireland has stabilised 7. 
Based on 2014 figures, there are an estimated 18,988 opiate users in Ireland. While the overall 
prevalence is stabilising, the spread of opiate use across the country is apparent, although 
highest prevalence rates are still recorded in Dublin.
One of the most devastating consequences of problem drug use is drug-related poisonings 
that lead to a loss of life. Data from the National Drug-Related Deaths Index (NDRDI), a national 
surveillance database which records drug-related deaths (such as those due to accidental and 
intentional overdose) and deaths among drug users (such as those due to Hepatitis C and HIV), 
shows overdose deaths increased in Ireland from 301 in 2005 to 354 in 2014, representing an 
increase of 17.6% 8.
New patterns of drug use and related harms have emerged over the past decade that need to 
be considered in developing an effective response to the drug problem. These include high risk 
behaviours associated with substance use, increased use of cannabis and ecstasy, particularly 
amongst younger people, and a rise in cannabis-related problems that may be associated with 
the increased use of more potent strains of domestically produced herbal cannabis.
Against this background, the Minister with responsibility for the National Drugs Strategy has 
been tasked by Government to put a new strategy in place which would address current and 
emerging challenges into the future.
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Methodology
Steering Committee
On 8 December 2015, the Minister of State with responsibility for the National Drugs Strategy 
established a Steering Committee to advise on the development of a new strategy and 
appointed an independent chair to guide the Committee in its work. The Terms of Reference 
of the Committee were as follows:
l Provide guidance and advice to assist the Minister of State in the development of a new 
National Drugs Strategy from 2017 onwards;
l Develop an integrated public health approach to substance misuse, which is defined 
as the harmful or hazardous use of psychoactive substances including alcohol and illicit 
drugs, incorporating the relevant recommendations of other related policies including 
the National Substance Misuse Strategy 9;
l Review the report of the Expert Review Team on the National Drugs Strategy 2009-
2016 10 and the evidence briefing by the Health Research Board on the drugs situation 
in Ireland 11 and international best practice in responses 12;
l Review the operational effectiveness of the structures and co-ordination mechanisms 
of the National Drugs Strategy, including the Drug and Alcohol Task Forces, NACDA, 
NDRIC, OFD, NCC and carry out a SWOT analysis on the partnership approach;
l Examine the relevance of the existing Strategy in tackling the current nature and extent 
of problem drug use in Ireland, including emerging trends and cross-cutting issues having 
regard to the available research, information and data sources. This will identify any gaps 
presenting and indicate how they might be addressed;
l Examine developments in drug policies and identify international best practice in dealing 
with problem drug use generally, at EU and International level;
l Conduct a consultative process and draw conclusions from same;
l In light of the foregoing, consider how a new Strategy post-2016 should address problem 
drug use, including the structures through which this could be done, and incorporating 
performance indicators to measure the future effectiveness of the new Strategy; and
l Present Report to the Oversight Forum on Drugs for discussion and submission to 
the Minister of State, who will submit the proposals for a new Strategy to the Cabinet 
Committee on Social Policy and Public Service Reform for approval.
The Committee met 19 times and its membership is set out at Appendix 1.
Focus Groups
To enable engagement with statutory, community and voluntary bodies who have a role in the 
delivery of the objectives of the Strategy, the Steering Committee convened four focus groups. 
Each focus group was asked to give their views on the relevance of the current strategy in 
responding to problem drug use in Ireland, to identify any gaps presenting, and to indicate how 
they may be addressed. To ensure the independence of the process, the Chair of the Steering 
Committee also chaired the focus groups. A focus group was established to examine each of 
the following areas:
l Supply reduction;
l Education and Prevention;
l Continuum of care, encompassing treatment, rehabilitation and recovery; and
l Evidence and best practice.
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Each focus group produced a position paper proposing measures to address gaps in the 
current response to the drug problem, which were considered by the Steering Committee 
and formed the basis for the strategic action plan.
Public Consultation
This strategy was informed by a public consultation which was undertaken by RPS Project 
Communications, (part of the RPS group), on behalf of the Department of Health. The aim 
of the public consultation was to engage with the general public, people who use services, 
families, communities and organisations across society and to obtain their views on the drugs 
issue in Ireland to help inform the new strategy. Specifically, the public consultation sought to 
obtain views from the public on:
l the supply reduction, prevention, treatment, rehabilitation and research pillars 
of the 2009-2016 National Drugs Strategy;
l the key issues that the Department of Health should consider in the development 
of the new strategy;
l the roles involved in the management of the drugs issue in Ireland; and
l emerging trends about drugs misuse in Ireland.
A range of options were provided for feedback, including email, post, telephone, an online 
questionnaire or through attendance at 6 regional events held in Carrick-on-Shannon, Limerick, 
Cork, Dublin, Galway and Kilkenny. A separate questionnaire was developed for young people to 
ensure that everyone who would be affected by the new drugs strategy had the opportunity to 
inform and shape it.
Nearly 3,000 individuals and organisations from across Ireland provided feedback to the public 
consultation. A breakdown by background of 2115 respondents to the on-line questionnaire 
is set out in Figure 1. 835 respondents did not indicate any of the choices available and are 
categorised as “unspecified”.
Figure 1: Summary of background information provided by respondents
Individual  641
Service user  65
Professional  352
On behalf of organisation  76
Carer  29
Other  117
Unspecified  835
Source: Public Consultation Report.63
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The following is a summary of the key issues raised repeatedly by respondents in the language 
provided via the submissions and questionnaires. The full findings are detailed in the public 
consultation report, which is available at: http://health.gov.ie/
Perceptions of the National Drugs Strategy
l While 27% of those responding to the consultation questionnaire were aware that Ireland 
had a drugs strategy, overall awareness was low.
l Of those who were aware, there was feedback that the strategy was broad-ranging, 
comprehensive and focussed, and has ensured Ireland’s drugs issues remain on the 
national agenda.
l Those who cited awareness of the Strategy felt that it was well assembled in terms of 
content and is largely consistent with the drug strategies and action plans of many other 
EU Member States.
l There was also feedback that the pillar structure is not integrated/co-ordinated enough.
Supply Reduction
l The need to change negative attitudes towards people who use drugs was a recurring 
theme, with calls for drug misuse to be treated as a medical and health issue, rather than 
a criminal issue.
l Drugs are not just a city or urban issue but are available throughout Ireland in small towns 
and villages and rural areas. Drugs are also an issue across all social demographics.
l Reducing supply is only part of the problem – demand is what drives availability and the 
reasons for demand need to be addressed.
l Many people who use drugs said they are subjected to debt intimidation and violence.
l Legal and illegal drugs should be reclassified based on their level of risk for real physical 
and/or mental harm.
l There were calls for legalisation and/or decriminalisation of drug use.
l The potential medical benefits of cannabis were cited frequently in questionnaire 
responses, with calls for cannabis to be legalised for medical use and available on 
prescription for this purpose.
l There were also calls, on a lesser scale, for other addictions such as gambling, tobacco 
and caffeine to be considered within the strategy.
Prevention
l Alcohol should be recognised as a major drugs issue in Ireland, particularly among 
younger people and alcohol should be integral to the new strategy.
l Education should begin in primary school and many service users felt children aged 6-11 
should be provided with factual information about the effects of drugs.
l More education and public awareness campaigns are needed and information should be 
provided through schools, parents, communities, television, internet, social media and 
mobile phone apps.
l There should be a focus on mental health as a means to address prevention.
l Calls for services for children to be improved, including safeguarding for young people 
whose families/caregivers are affected by addiction.
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Treatment
l Service users want a sense of choice and to have a say in their treatment options.
l Fear of legal ramifications and stigma was suggested as a barrier to seeking treatment 
for illegal drug use.
l There were views in support of and against injection centres.
l Calls for more GPs to be involved in prescribing methadone, particularly outside the 
Dublin area, and in promoting and encouraging detoxification.
l There were calls for Suboxone to be provided as an alternative to Methadone and for the 
wider roll-out of the opioid overdose anti-dote, Naloxone.
l A belief that there are significant blocks in the system for people who have both a mental 
health and addiction issue was a recurring theme.
l A lack of transport and significant travel times for those in rural communities was cited as 
a significant barrier to accessing services.
l People are coping with rural isolation through the use and misuse of legal drugs such as 
alcohol and prescription drugs.
l A need was identified for designated assessment centres in the community for all drugs 
and alcohol use, with care-pathways to other supportive specialist services in primary 
care, community services, tertiary services and residential services.
l There are no programmes aimed at the recreational drug user who may not consider 
themselves addicted to drugs.
l There was feedback that a holistic approach to treatment is needed with greater inter-
agency working, communication and co-ordination.
Rehabilitation
l People should be helped to meet their goals using a case management process, and 
service users should have a distinct say in their own rehabilitation.
l Families should have a role in in treatment and rehabilitation; there is a need for services 
for families; and for them to be more integral to how services are developed.
l To maintain recovery requires a range of services, including housing, family support, 
education, community employment (CE) programmes, free legal aid, social welfare advice 
and budgeting services and support to return to employment.
l Many called for mutual aid, support networks and continued aftercare to be made more 
widely available, including mutual aid, such as AA, for younger people.
Research
l A wide range of research themes were identified, including research into:
n how addictive and damaging occasional use of different substances is;
n the extent and patterns of substance use in Ireland (including rural areas);
n what substances are most misused and underlying reasons for use;
n accurate death tolls;
n “secret” behaviours, such as drinking in middle class homes; and
n the cost effectiveness of the ‘war on drugs’.
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Evidence Review
The Health Research Board (HRB) commissioned the Centre for Public Health at Liverpool 
John Moores University to prepare a trends analysis on the drugs situation in Ireland 11 and a 
report on the most recent international evidence on responses to problem drug use 12. The 
drugs situation in Ireland: an overview of trends from 2005 to 2015 11 reviews the current drug 
situation in Ireland, analysing ten years of data up to the most recent data available with 
respect to the five European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) key 
indicators (prevalence of drug use, high risk drug use, treatment demand, drug-related deaths 
and mortality and drug-related infectious diseases) as well as drug-related crime and supply. In 
addition to presentation of national trends, this report includes additional evidence looking at 
trends in data relating to specific sub-populations including people who inject drugs, prisoners, 
homeless individuals, sex workers and the Travelling community.
The effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, 
treatment and recovery. A ‘review of reviews’ 12 examines evidence on effective delivery of 
interventions in the areas of prevention, harm reduction, treatment and recovery relating to illicit 
drug use with the overarching aim of reducing the use of illicit drugs and related harms, and 
increasing successful recovery and rehabilitation following drug misuse.
The primary research questions for this review were:
l Which interventions are effective for reducing the initiation, or continued use, of illicit 
drugs and related harmful behaviours amongst children and young people aged up to 25 
years?
l Which interventions are effective for reducing harmful behaviours related to illicit drug 
use?
l Which interventions are effective at treating drug misuse amongst people who misuse or 
who are dependent upon illicit drugs?
l What interventions are effective at supporting people who misuse illicit drugs to fully 
recover from their illicit drug misuse and become better reintegrated into the community 
following/alongside treatment?
The review highlighted a number of drug prevention, harm reduction and treatment 
interventions that are supported by evidence as having positive effects on drug-related 
outcomes.
Rapid Expert Review
The Minister appointed an independent international expert panel to carry out a rapid review of 
the 2009-2016 strategy 10. The panel was chaired by Paul Griffiths, Scientific Director, EMCDDA 
and included Professor Sir John Strang, Director, National Addictions Centre, Kings College 
London and Nicola Singleton, Scientific Analyst, EMCDDA. The main objectives of the Rapid 
Expert Review were to examine the progress and impact of the strategy and to highlight areas 
for consideration in the development of this Strategy.
The expert panel considered the 2009-2016 strategy to have been ‘well-crafted and 
comprehensive’ when compared to other European strategies and focused on issues that 
were a priority at the time, such as heroin use, particularly in inner city areas. Several issues 
have emerged since 2009, which require an up-to-date response in the opinion of the panel, 
in particular, the use of cocaine, new psychoactive substances, and the emergence of a more 
diverse social profile of users, including an aging population of opioid users. Their report also 
noted that the drug market has become increasingly globalised and that the internet has 
presented particular challenges to law enforcement.
14 Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
Many key stakeholders interviewed by the panel highlighted the fact that the current Drug 
and Alcohol Task Force boundaries were no longer adequately reflecting the pattern of drug 
problems around the country. As a result, the panel formed the view that there are gaps in 
service provision and inequitable allocation of resources. They recommended a review of Task 
Force boundaries in light of current needs and suggested that the results of the 2014/15 general 
population survey and estimates of opiate prevalence would provide a good basis for such a 
review.
The panel considered that the five pillar format of the strategy, which focused on supply 
reduction, prevention, treatment, rehabilitation and research, had encouraged joined up inter-
agency working, but may have been unhelpful in facilitating cross-pillar coordination where 
actions related to a number of pillars. To provide greater coherence, they recommended an 
overarching long-term vision, a few key goals with specific objectives, related actions and 
appropriate performance indicators. They also highlighted the importance of developing 
synergies with other relevant strategies, such as the alcohol-focused National Substance Misuse 
Strategy 9, mental health strategies and policy documents related to homelessness and Healthy 
Ireland.
For the future, they recommended that the strategy should focus on achieving equality of 
access to evidence-based services that adhere to quality standards and are responsive to 
changing needs, such as new drugs, new patterns of use and new groups of users. They said 
that the perspective and engagement of those affected by substance misuse should be integral 
to the process of developing the new strategy.
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CHAPTER 2 – Vision, Values and Goals
Vision
The vision of the strategy aims to create:
 “A healthier and safer Ireland, where public health and safety is protected, and the 
harms caused to individuals, families and communities by substance misuse are reduced 
and every person affected by substance misuse is empowered to improve their health, 
wellbeing and quality of life.”
This vision recognises the importance of responding to the harms caused by substance misuse 
which impacts on individuals, families, communities and wider society, and helping those who 
develop drug or alcohol problems to address their personal health needs and improve their 
health, wellbeing and quality of life.
Values
The new strategy is guided and underpinned by the following values:
l Compassion
 A humane, compassionate approach focused on harm reduction which recognises that 
substance misuse is a health care issue.
l Respect
 Respect for the right of each individual to receive person-centred care based on his or 
her specific needs and to be involved in the development of their care plan.
l Equity
 A commitment to ensuring people have access to high quality services and support 
regardless of where they live or who they are.
l Inclusion
 Diversity is valued, the needs of particular groups are accommodated and wide-ranging 
participation is promoted.
l Partnership
 Support for maintaining a partnership approach between statutory, community and 
voluntary bodies and wider society to address drug and alcohol issues.
l Evidence-informed
 Support for the use of high quality evidence to inform effective policies and actions to 
address drug and alcohol problems.
Taken together, these values underpin the goals, objectives and actions in this strategy and 
reinforce the Government’s commitment to adopt a health-led approach to substance misuse 
and to provide the supports that are necessary to help people recover their health, wellbeing 
and quality of life.
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Goals
Goal 1
Promote and protect health and wellbeing
A healthy population is a major asset for society, and improving the health and wellbeing of 
the nation is a priority for the Government and the whole of society. Healthy Ireland 3, Ireland’s 
framework for improved health and wellbeing, aims to support people and communities in 
making more positive changes, to address the social determinants of health and thereby reduce 
health inequalities, and to influence the wider environment to enable healthier choices by 
everyone. This strategy aims to protect the public from threats to health and wellbeing related 
to substance misuse by preventing early use of alcohol and other drugs among young people, 
influencing behaviour and challenging social norms and attitudes and providing targeted 
interventions aimed at minimising harm for those who have already started to use substances.
Goal 2
Minimise the harms caused by the use and misuse of substances and promote 
rehabilitation and recovery
This goal recognises the role of the individual in addressing his or her dependence on 
alcohol and other drugs, and that the context within which drug dependency develops has 
a fundamental impact on the type of response that is most appropriate to addressing it. It 
also acknowledges that substance misuse affects not only those who have developed a drug 
or alcohol problem, but also their families, the community and the wider society. Therefore, 
interventions and supports are needed to target not only those who have developed a problem 
due to the misuse of substances, but also those harmed by another person’s drug and alcohol 
use. It is also important to provide tailored interventions to effectively address the needs of 
those who face a higher risk of substance misuse because of their lifestyle or because they 
belong to a specific group or community of interest.
Goal 3
Address the harms of drug markets and reduce access to drugs for harmful use
Protecting the public from dangerous or potentially dangerous substances and their harmful 
effects is a core objective of Ireland’s drug control framework. Gathering information and 
intelligence at national and international level is a vital part of the work involved in intercepting 
drugs destined for the Irish drug market. It strengthens the response to organised and 
gang-related crime, involved in the supply of drugs and related criminal activities. Effective 
monitoring of the drugs situation, and the public health threats associated with the supply of 
illegal substances, including new drugs, is required to address the harms of the drug market and 
reduce access to drugs for harmful use. Addressing the harmful aspects of the drugs situation 
in communities, such as drug-dealing and drug-related crime and intimidation, requires a 
collaborative effort, across a range of agencies and sectors of society.
Goal 4
Support participation of individuals, families and communities
Building the capacity of communities to respond to the drugs situation is a key goal of 
Reducing Harm, Supporting Recovery. Building social capital is seen as particularly important 
in those communities that are most impacted by socio-economic disadvantage, marginalisation 
and exclusion, as such communities may require more targeted interventions to address the 
issues they face. The full involvement of all stakeholders, including people who use services and 
others affected by problem substance use, in the design, implementation and review of services, 
policies and strategies is also of vital importance. Throughout this strategy, the term service 
17Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
user is used to include people who use healthcare services, their parents, guardians, carers and 
families, organisations and communities that represent the interests of people who use health 
and social care services, as well as potential users of healthcare services such as people who 
currently use drugs. Family members have a particularly important role to play, as they may be 
involved in supporting a loved one with a drug problem and may be service users in their own 
right.
Goal 5
Develop sound and comprehensive evidence-informed policies and actions
Improving our knowledge and understanding of the drugs problem is a core objective of 
Reducing Harm, Supporting Recovery. For this reason, a sound and comprehensive evidence-
base is needed for policies and actions. Information systems which monitor trends and patterns 
in drug use and availability, evaluation of programmes and research into the causes and 
consequences of substance misuse will be supported under the new strategy.
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CHAPTER 3 – Goal 1: Promote and protect 
health and wellbeing
Introduction
As a nation, we are seeing increasingly higher rates of substance use. One in four (26.4%) adults 
has tried an illegal drug at least once in their lifetime and about 24% of the population have 
used cannabis at some point in their lives. The 2014/15 All Ireland Drug Prevalence Survey 6 
shows higher rates of cannabis use in the last year, (an indicator of recent use) and last month, 
(an indicator of current use), than previous surveys. As illustrated in Figure 2 below, the rising 
trend in last year cannabis use evident in Ireland can also be seen in other northern European 
countries, while the long-term decreasing trends in Spain and the United Kingdom have 
stabilised 13.
Figure 2: Last year prevalence of cannabis use among young adults (15-34): 
selected trends
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Ireland also has a high level of alcohol consumption and many Irish people engage in 
harmful drinking patterns which have significant health, social and economic costs. Alcohol 
consumption in 2014 was 20.9% higher than the target of 9.1 litres per capita per annum, 
recommended in the National Substance Misuse Strategy. Survey data from the 2013 National 
Alcohol Diary Survey 14 indicate that drinkers in Ireland consume alcohol in an unhealthy pattern;
l 37.3% of drinkers engaged in monthly risky single-occasion drinking (RSOD), more 
commonly known as binge drinking, in the previous year;
l 54.3% of drinkers had a positive score on the AUDIT-C screening tool and would be 
classified as harmful drinkers, indicating that 1.35 million harmful drinkers in Ireland;
l 6.9% scored positive for dependence, which indicates that there were somewhere 
between 149,300 and 203,897 dependent drinkers in Ireland in 2013; and
l At least three-quarters of the alcohol consumed was done so as part of a risky 
single-occasion or binge drinking session.
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Figure 3: Harmful drinking patterns among 18–75-year-old Irish drinkers 
(National Alcohol Diary Survey 2013)
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The figures presented here are probably an underestimate of the extent of harmful drinking as 
there is strong evidence that surveys of self-reported alcohol consumption result in estimates 
of per capita consumption well below the level calculated from alcohol sales data.
People who use substances in a harmful way can be influenced by a complex set of factors, 
including the publicity messages to which they are exposed, the availability of alcohol, tobacco 
and illegal drugs and social, cultural and environmental norms.
This strategy adopts a population health approach to addressing the underlying reasons 
for substance misuse, recognising that behaviour change is complex, challenging and takes 
time. It puts the needs of people and communities at the centre of the response to substance 
misuse and empowers people to take charge of their own health. It reinforces key measures 
in the National Substance Misuse Strategy 9, which aim to support people and communities 
in making more positive changes and to influence the wider environment so that the healthier 
choice is the easier one for everyone. It complements the Public Health (Alcohol) Bill 15, which 
contains the proposed legislative provisions to provide a public health response to issues 
associated with alcohol consumption in Ireland.
The measures contained in the Public Health (Alcohol) Bill relate to the recommendations 
contained in the Steering Group Report on a National Substance Misuse Strategy. The Public 
Health (Alcohol) Bill aims to reduce alcohol consumption and to reduce the harms associated 
with alcohol.
The strategic objectives of the Bill are to:
l reduce consumption to the OECD average by 2020 (i.e. 9.1 litres of pure alcohol 
per capita).
l ensure that the supply and price of alcohol is regulated and controlled in order 
to minimise alcohol related harm and
l delay children and young people using alcohol.
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Recognising that there is no single simple answer, the Public Health (Alcohol) Bill includes a 
range of measures designed to collectively have a positive impact on the health and well-being 
of Irish people. Those measures include introducing a minimum unit price for alcohol, health 
labelling on products that contain alcohol, restrictions on the advertising and marketing of 
alcohol, the separation of alcohol products in retail outlets and the regulation of sponsorship 
and promotions.
Objective 1.1: Promote healthier lifestyles within society
Substance misuse prevention strategies targeting families, schools and communities are an 
effective way of promoting health and wellbeing among the general population and result in 
wider benefits for society in terms of savings in future health, social and crime costs. Prevention 
strategies include measures to prevent early use of alcohol and other drugs among young 
people, reduce the misuse of alcohol and other drugs, and minimise harm, where drug use has 
already started.
Raising awareness of the risks of substance use and increasing understanding of the harmful 
effects of substance misuse on the health of the user and other people in the person’s life is 
an important part of the work of prevention. DATFs have made a significant contribution in 
this area through organising local and regional awareness initiatives and promoting evidence-
based approaches to community action on alcohol that raise awareness of alcohol-related harm. 
Support for these initiatives will continue under the new strategy.
Evidence suggests that education and awareness programmes that are delivered alongside 
other measures, which build the lifeskills and confidence necessary to support positive 
behaviours and choices, are more likely to be effective in encouraging protective and healthy 
behaviour than stand-alone measures. On the other hand, initiatives that use scare tactics or 
testimonials from ex-drug users to discourage drug use can be counterproductive and may 
have little impact on changing behaviour 12.
Effective drug prevention involves integrated holistic policies and actions, which take account 
of the different risk factors for substance use, such as parental substance misuse, family 
circumstances, peer pressure, school or work life, lifestyle reasons and socio-economic factors. 
Promoting a joined up approach between different government policies and strategies that 
may have a bearing on the risk factors for substance misuse is important in this context.
Prevention is a collaborative effort, which involves a range of stakeholders, including parents 
and families, those working in education, DATFs, family support networks, youth services, 
student unions, sporting organisations and networks of people who use drugs. Prevention 
programmes should be evidence-based, adhere to quality standards and involve participants 
in programme design and implementation.
Using manual-based programmes, which set out the practical aspects of the intervention and 
ensuring programmes are implemented and regularly evaluated, all increase the likelihood 
of success and better outcomes. A coordinated and consistent approach to prevention and 
education interventions will be achieved by supporting specific capacity building initiatives 
aimed at the relevant sectors and interests groups involved in drug and alcohol education.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.1.1 Ensure that the 
commitment to an 
integrated public health 
approach to drugs and 
alcohol is delivered as a 
key priority.
a) Developing an initiative to ensure 
that the commitment to an 
integrated public health approach 
to drugs and alcohol is delivered 
as a key priority; and
b) Promoting the use of evidence 
based approaches to mobilising 
community action on alcohol.
DOH HSE, 
DATFs
1.1.2 Improve the delivery of 
substance use education 
across all sectors, 
including youth services, 
services for people using 
substances and other 
relevant sectors.
a) Organising a yearly national 
forum on evidence-based and 
effective practice on drug and 
alcohol education; and
b) Developing a guidance 
document to ensure substance 
use education is delivered 
in accordance with quality 
standards.
HRB HSE, 
DOH, 
DES, 
DCYA
Objective 1.2: Prevent use of drugs and alcohol at a 
young age
Better Outcomes, Brighter Futures 16, the national policy framework for children and young 
people, 2014-2020, provides an additional context for this strategy to promote and protect 
the health and wellbeing of children and young people. In particular, Better Outcomes, Brighter 
Futures commits to a whole-of-Government and whole-of-society approach to supporting 
children and young people achieve good physical, mental, social and emotional health and 
wellbeing to make positive choices to be safe and protected from harm and realise their 
potential.
Preventing or delaying substance use aims to reduce the negative health and social 
consequences of drug and alcohol use in society and is therefore an important element in 
promoting healthier lifestyles and a healthy society generally. Using substances at a young 
age increases the likelihood of developing problems with alcohol and other drugs later in life. 
There are physical health risks associated with drug and alcohol use, and adolescents who 
use the substances expose themselves to those risks over a longer period of time. Family 
circumstances, socio-economic status and a lack of educational attainment can be underlying 
reasons for early substance use, and drug use in adolescents frequently overlaps with other 
mental health problems.
Surveys from the past ten years show that the greatest increases in drug use are amongst 
younger people 6. Figure 4 illustrates that the proportion of young people consuming illegal 
drugs in the last year has risen since 2002/03. Last year use of ecstasy among 15-34 year olds 
rose sharply from 0.9% in 2010/11 to 4.4% in 2014/15.
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Figure 4: Last year prevalence of substance use among 15-34 year olds
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Data Source: Prevalence of drug use and gambling in Ireland and Northern Ireland. Bulletin 1
The proportion of 15-34 year olds reporting using cannabis in the last month has almost 
doubled since 2010/11 as illustrated in Figure 5.
Figure 5: Last month prevalence of cannabis use (%)
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School-based interventions
Most universal prevention programmes take place in an educational setting. In Ireland, 
substance use education in primary and post primary schools has been developed through 
Social, Personal and Health Education (SPHE). The 2015 Life Skills Survey (forthcoming) 
indicates that more than 90% of schools provide their students with information on alcohol 
and drug misuse through SPHE and other means and that 95% of post primary schools have, 
or are progressing, a substance abuse policy. DATFs can play a valuable role in supplementing, 
complementing and supporting a planned, comprehensive and established SPHE programme.
Building the capacity of young people to take charge of their own physical and mental health 
and wellbeing is at the heart of a whole-school health promotion approach to substance misuse. 
The Action Plan for Education 17 aims to ensure resilience and personal wellbeing are integral 
parts of the education and training system.
Evidence suggests that comprehensive school-based programmes that combine social and 
personal development and provide information about substance use are more likely to be 
effective in preventing early substance use. This is the approach recommended in the Action 
Plan for Education 17 and will be a key component of a new wellbeing area of learning to be 
introduced at Junior Cycle level from 2017 onwards.
Schools will have flexibility in designing their Wellbeing Programme to ensure that it suits their 
students and their local context. They will be encouraged to work towards a shared vision 
and set of indicators which describe what is important. Activity, responsibility, connectedness, 
resilience, respect and awareness are the six indicators which have been identified as central to 
wellbeing.
It will also be important to ensure that SPHE teachers, guidance counsellors and Home School 
Liaison co-ordinators are given the opportunity to avail of continuing professional development 
to build their capacity to deliver substance use education in line with the Action Plan.
In addition, Wellbeing Guidelines that provide a clear and rational structure to support the 
promotion of health and wellbeing in all schools, have been developed by the Department of 
Education and Skills, the Department of Health and the Health Service Executive and the Action 
Plan is committed to the roll out of a national programme to support the implementation of 
these guidelines in all primary and post-primary schools.
Out-of-school interventions
Youth services
Youth services play an important role in developing the confidence, social skills, wellbeing 
and resilience of young people. The Department of Children and Youth Affairs’ Value for Money 
Policy Review (VFMPR) 18 in 2014 recommended changes to youth funding programmes to 
ensure evidence-based, effective, value for money services that secure the best outcomes 
for young people, particularly, vulnerable young people.
The VFMPR examined three targeted programmes including the Young People’s Facilities 
and Services Fund (YPFSF), which was established in 1998, as part of the Government’s overall 
strategy to address drug misuse, in order to assist with the development of youth facilities 
(including sport and recreational facilities) in areas where a significant drug problem exists or 
has the potential to develop. The review recommended amalgamation of the three programmes 
into one targeted programme for youth, as there was significant cross-over in the ‘types’ 
of needs targeted by the programmes, in particular addressing concerns relating to drugs 
misuse, crime/anti-social behaviour and educational disadvantage. This recommendation was 
accepted by Government and is now Government policy. The target groups of young people 
are unchanged under the new scheme.
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The review recommended that service provision for young people would aim to achieve seven 
key outcomes which could have a positive impact on delaying the onset of substance misuse. 
These seven outcomes are:
l Communication,
l Confidence/agency,
l Planning and problem-solving,
l Relationships,
l Creativity,
l Resilience and determination, and
l Managing feelings.
In order to address the above outcomes, DATFs will be supported to develop targeted, 
appropriate and effective services for young people at risk of substance misuse, focused on 
social and economically disadvantaged communities.
Family-based interventions
Children living in communities with higher prevalence of problem substance use are at 
increased risk of developing problems themselves. For some of these children there are early 
identifiable behaviour patterns that indicate possible problems with substances later in life 12. 
Personal trauma or life difficulties are associated with risk taking and resultant harm and very 
particular, targeted programmes may offset these risks and reduce the possibility of future 
harms. However, these risk factors are not always apparent and even those who may not be 
identified as being at risk may develop substance use problems given certain conditions.
Parental involvement and concern are the most important protective factors when it comes 
to consuming alcohol, cannabis and other drugs for both early-school leavers and those who 
remain in school. Substance use by either parent may increase the likelihood of young people 
consuming the same substance. On the other hand, a family environment in which substances 
are not used on a regular basis can reduce this risk by limiting experimentation at a young age 
and providing positive role models. Awareness of these risk and protective factors can provide 
parents with the tools to protect their children against the risks of early substance use.
Young people living with family members who have substance use problems can be supported 
through the use of programmes specifically designed for these groups and delivered in informal 
settings by youth workers and other support staff. Family-based interventions may reduce 
initiation and use of cannabis among adolescents and this approach may be particularly 
beneficial in communities most affected by problem drug use 12.
Early school leaving and substance use
Early school leaving rates in Ireland currently stand at 6.9%, compared with an EU average of 
11% 19. Nonetheless, those who leave school early are an important target group for prevention 
programmes, as there is a substantial overlap between risk factors for early school leaving and 
substance use. A 2010 study 20 found that those who left school before completion were more 
than twice as likely to have tried cannabis and other drugs, while having a positive experience 
of school and learning reduces the risk of substance misuse. Recent educational research 21 
shows that student disaffection, a lack of connectedness to school, as well as a poor school 
climate, are themes in accounts of early school leaving.
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Social class and gender can influence the risk of early school leaving. Developmental issues, 
emotional and behavioural disorders, mental health concerns, poor attainment and learning 
disabilities are also risk factors, which can lead young people to struggle with the curriculum, 
peer relationships and the school community. This can result in a gradual disengagement, early 
school leaving and consequent greater risks of substance misuse.
There are a number of initiatives and programmes that aim to address the factors that influence 
early school leaving and improve school retention rates. These include:
l the School Completion Programme and the Home School Community Liaison Scheme;
l the Department of Education’s Programme “Delivering Equality of Opportunity in 
Schools” (DEIS), which has seen significant improvements in retention rates in DEIS 
schools in recent years;
l Meitheal, the TUSLA national practice model, an interagency model of work to ensure the 
effective delivery of services for “at risk” young people; and
l the Department of Housing, Planning and Local Government’s Social Inclusion and 
Community Activation Programme (SICAP), which provides supports to children and 
young people from target groups who are at risk of early school leaving and/or not in 
employment, education or training aged between 15 and 24.
Providing a continuum of support and ensuring access to resilience building programmes, 
counselling/guidance supports, educational or psychological assessments are ways in which 
young people at risk of early school leaving can be supported. There are a number of further 
measures planned in the coming years which aim to benefit young people who may be at risk of 
disengaging from school.
During 2017, a School Completion Strategy will be developed by the Department of Children 
and Youth Affairs in collaboration with TUSLA Educational and Welfare Services and the 
Department of Education and Skills and a review of senior cycle programmes and vocational 
pathways will be undertaken by the Department of Education and Skills to ensure that those 
who do not seem to thrive in a traditional academic setting complete their education. The 
review will include all those in the 16–18 age range and cover the range of programmes and 
vocational pathways currently provided in this regard – Leaving Certificate, Leaving Certificate 
Applied, Leaving Certificate Vocational Programme, Transition Year, Youthreach and Community 
Training Centres, Special Education, and other relevant programmes.
The State has invested a lot of resources in providing some excellent facilities for schools. The 
availability of such school facilities outside the times they are required to deliver mainstream 
education could facilitate many positive initiatives, particularly in disadvantaged areas, such as 
sport, recreation, music and artistic activities. This would enable communities to meet the needs 
of young people and the wider community much more effectively, at little extra cost to the 
State.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.2.3 Support the SPHE 
programme.
a) Promoting continued effective 
communications between local 
schools and Drug and Alcohol 
Task Forces given the importance 
placed on the continued building 
of strong school community links; 
and
b) Ensuring that all SPHE teachers, 
guidance counsellors and Home 
School Community Liaison co-
ordinators can avail of continuing 
professional development.
DES, 
DATFs 
(Joint) 
 
 
 
DES
1.2.4 Promote a health 
promotion approach to 
addressing substance 
misuse.
In line with the Action Plan for 
Education
a) Commencing and rolling out 
a national programme to 
support the implementation 
of the Wellbeing Guidelines to 
all primary and post-primary 
schools; and
b) Developing Wellbeing Guidelines 
for Centres of Education and 
Training.
DES DOH/
HSE
1.2.5 Improve supports for 
young people at risk of 
early substance use.
a) Providing a continuum of support 
including a Student Support Plan 
as appropriate, for young people 
who are encountering difficulty in 
mainstream education;
b) Providing access to timely 
appropriate interventions such as 
resilience-building programmes, 
and/or counselling, educational 
assessments and/or clinical 
psychological assessments, as 
appropriate;
c) Implementing School Attendance 
Strategies in line with TUSLA’s 
guidance;
d) Prioritising initiatives under the 
new DEIS programme to address 
early school leaving; and
e) Providing supports including 
homework clubs, additional 
tuition, career guidance/
counselling support, community 
awareness of drugs programme 
and youth work in collaboration 
with schools and other youth 
programmes/schemes.
DES 
 
 
 
DES
HSE
TUSLA
(Joint 
Leads) 
TUSLA
 
 
DES
 
 
DHPLG
HSE 
 
 
 
 
 
 
 
 
 
 
DES
 
 
TUSLA
1.2.6 Ensure those who do 
not seem to thrive in 
a traditional academic 
setting complete their 
education.
Reviewing Senior Cycle programmes 
and Vocational Pathways in senior 
cycle with a view to recommending 
areas for development.
DES
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.2.7 Facilitate increased use 
of school buildings, 
where feasible, for 
afterschool care and out 
of hours use to support 
local communities.
Engaging with property owners 
and school authorities to facilitate 
increased use of school buildings, 
where feasible, for afterschool care 
and out of hours use to support local 
communities.
DES
1.2.8 Improve services for 
young people at risk 
of substance misuse in 
socially and economically 
disadvantaged 
communities.
Developing a new scheme to provide 
targeted, appropriate and effective 
services for young people at risk of 
substance misuse, focused on socially 
and economically disadvantaged 
communities.
DOH DCYA, 
HSE, 
DATF.
Objective 1.3: Develop harm reduction interventions 
targeting at risk groups
Children at risk
Children of parents who misuse substances are more likely to be at a higher risk of physical, 
psychological and emotional harm, compared to children whose parents do not misuse drugs or 
alcohol 22. As the effects of parental substance misuse on children can be difficult to detect, this 
phenomena is often described as “Hidden Harm.”
Not all children in homes where substances are misused experience harm as a result, but 
children living with parental problem substance use are more likely to experience mental 
health problems, academic under-achievement, have poor social skills and be more prone to 
developing substance misuse problems themselves later in life. Genetic factors combined with 
physical and emotional neglect and exposure to poor parenting can impact on a child’s social 
and emotional maturation, development of social competencies and undermine reliance and 
the capacity for emotional regulation, all established determinants for substance misuse in 
adulthood.
Analysis of general population survey and treatment data can provide estimates of the numbers 
of children of parents who misuse substances and may help in determining the scale of the 
interventions needed to respond to this problem. For family-based interventions, prevention 
experts recommend approaches that involve the whole family rather than those that train 
parents alone.
Evidence suggest that prevention interventions targeting those at risk may be more effective 
if they involve both schools and parents, are interactive and have positive goals. There is some 
evidence that family interventions may be effective in delaying or reducing drug use but 
there is not a great deal of research on family interventions targeted at children of drug-using 
parents 23.
A coordinated response to the needs of children in families where substances are misused will 
help to protect these children from harm. Addiction and other services providing support to 
children can work closely together and agree protocols for exchanging information, agreeing on 
referrals and for sharing other responsibilities in this sensitive area.
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For young people with substance use problems, family therapies may be effective in reducing 
drug use frequency and severity in comparison to other interventions among adolescents, 
including cognitive behavioural therapy (CBT). For very young at-risk children, interventions 
that are aimed at strengthening relationships between children and their parents and 
developing parenting skills can impact on child behaviour. As with universal prevention 
programmes these interventions are more likely to be successful if they are delivered by trained 
professionals through frequent sessions. There is a need to ensure continued support for family 
support programmes. Strengthening Families, Parenting under Pressure and the 5 step method 
(Stress-Strain-Coping-Support model) are examples of programmes that have been supported 
in Ireland to build the resilience of families and support them in their own right.
Children leaving care
Young people leaving care and detention services, particularly from residential or hostel 
accommodation, are more at risk than the general population of homelessness, mental health, 
addiction problems, and isolation. The Ryan Report 24 recommends that consideration be given 
as to how best to provide necessary once-off support to young people leaving care to help 
them gain practical life-long skills in order to reduce their risk of developing substance use 
problems. Specific psychological programmes and mental health information are necessary 
to help them build their resilience to cope as independent adults and to develop protective 
factors against substance use. The Meitheal interagency model can make a key contribution 
towards ensuring the delivery of effective services for ‘at risk’ young people who face multiple 
challenges, such as young people leaving care.
Risks associated with belonging to particular groups or sub-populations
Research suggests that third level students and Lesbian, Gay, Bisexual, Transgender and Intersex 
(LGBTI) young people may be far more likely to take illegal drugs and/or binge drink than the 
general population. The most recent results of the National Student Drug Survey 25 found that 
82% of respondents had tried illegal drugs, with 35% of respondents binge-drinking on at least 
a weekly basis. In an earlier online survey of LGBTI youth, 65% of respondents had taken drugs, 
the majority of which had taken some drug within the preceding month.
The “Men who have sex with men internet survey Ireland” 26 (MISI) published in 2016, reported 
that 36% of respondents had used recreational drugs within the previous 12 months: the most 
commonly used were cannabis (28%), MDMA (17%) and cocaine (13%). Over half (58%) of 
respondents reported that they binge drank on a typical drinking occasion, and 44% binge drink 
every week. Separately, a 2016 survey of men attending the Gay Men’s Health Service (GMHS) 
in Baggot Street, Dublin noted that 27% of respondents reported that they had engaged in 
chemsex (used drugs for or during sex) within the previous 12 months; the most commonly 
used drugs were gamma-hydroxybutyric acid/gamma-butyrolactone (GBH/GBL), cocaine, 
ketamine and chrystal methamphetamine.
While prevalence of new psychoactive substances (NPS) use is relatively low in the general 
population, the increase in the rate of deaths involving NPS from 8 in 2012 to 28 in 2013, and 
23 in 2014 is a cause for concern 8. Moreover polydrug use, including alcohol can increase the 
risks associated with NPS use. This underlines the ongoing need for targeted initiatives to raise 
awareness of the dangers and significant mental and physical health effects that can be caused 
by NPS use.
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Use of image and performance enhancing drugs (IPED) can also put people at risk. Service 
providers report an increase in clients of their needle exchange programmes who use IPED, 
such as steroids. Existing harm reduction services are traditionally geared towards users of 
psychoactive substances. Given the divergent profile and nature of substance use among 
IPED users, there is a need to develop a tailored approach in response to the profile of harm 
within this group. Expanding the range and nature of models of practice may serve to enhance 
accessibility, engagement, and effectiveness. There may be a case for developing a specialised 
IPED clinic for those currently using mainstream needle exchange services 27.
These findings point to the need for targeted harm-reduction, education and prevention 
measures that are tailored towards these higher risk groups. These may include education, 
information and interaction with people who use drugs in environments where drug taking can 
occur (e.g. festivals, nightclubs etc.). Harm reduction initiatives and drug welfare are becoming a 
mainstream part of festivals in many European countries and there have been similar initiatives 
in Ireland. The development of IT/web based drug education, harm reduction and brief advice 
tools targeted at 3rd level students, which have a component signposting to locally available 
supports, will be a key element of the prevention strategy. The development of such initiatives 
will need to be compatible with national drug prevention programmes and involve the relevant 
networks, such as student and LGBTI organisations. The engagement of people who use drugs 
and/or services in the development and roll-out of any awareness campaigns is particularly 
important to ensure relevance and accuracy.
Examples of awareness initiatives targeting 3rd level students include the “What’s In The Pill?” 
campaign, and SpunOut’s targeted online advertising. Online awareness campaigns along 
the lines developed by Drugs.ie, which use advertisements on Facebook and Twitter, as well 
as active engagement with online discussion sites and other online media outlets frequented 
by young people, play an important role in highlighting the risks of psychoactive substances. 
Similarly, targeted awareness campaigns, such as the Drugs.ie campaign on the use of GBH/
GBL, highlight particular issues among high-risk groups or about particular patterns of drugs 
use.
In order to respond to emerging trends such as high risk behaviours associated with lifestyle 
choices or risky patterns of substance use, a need has been identified to establish a working 
group to undertake an examination of the evidence on the effectiveness of early harm reduction 
responses, such as targeted information campaigns, drug-testing and amnesty bins to respond 
to emerging trends. This will be pursued by the HSE in conjunction with other relevant 
stakeholders.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.3.9 Mitigate the risk and 
reduce the impact of 
parental substance 
misuse on babies and 
young children.
a) Developing and adopting 
evidence-based family and 
parenting skills programmes for 
services engaging with high risk 
families impacted by problematic 
substance use;
b) Building awareness of the hidden 
harm of parental substance 
misuse with the aim of increasing 
responsiveness to affected 
children;
c) Developing protocols between 
addiction services, maternity 
services and children’s health 
and social care services that will 
facilitate a coordinated response 
to the needs of children affected 
by parental substance misuse; 
and
d) Ensuring adult substance use 
services identify clients who 
have dependent children and 
contribute actively to meeting 
their needs either directly or 
through referral to or liaison 
with other appropriate services, 
including those in the non-
statutory sector.
HSE, 
TUSLA
(Joint 
Leads)
NFSN
C&V 
sectors
1.3.10 Strengthen the life-skills 
of young people leaving 
care in order to reduce 
their risk of developing 
substance use problems.
Considering how best to provide 
necessary once-off supports for Care 
Leavers to gain practical life-long 
skills in line with Action 69 of the 
Ryan Report in order to reduce their 
risk of developing substance use 
problems.
TUSLA
1.3.11 Strengthen early harm 
reduction responses to 
current and emerging 
trends and patterns of 
drug use.
Establishing a working group to 
examine the evidence in relation to 
early harm reduction responses, such 
as drug testing, amnesty bins and 
media campaigns, to current and 
emerging trends including the use 
of new psychoactive substances and 
image and performance enhancing 
drugs and other high risk behaviours, 
including chemsex.
HSE DOH
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Performance indicators related to Goal 1
l Reduction in the use of illegal drugs in the last year (Drug Prevalence Survey).
l Reduction in the alcohol consumption rate (Drug Prevalence Survey).
l Increase in knowledge with respect to the harms of alcohol, cannabis and other drugs 
(Drug Prevalence Survey, other sources).
l Delaying the age of first use of illicit drugs (ESPAD survey).
l Delaying the age of first drink (Drug Prevalence Survey, ESPAD survey).
l Reduction in binge drinking among young people (ESPAD, Drugs Prevalence and HBSC 
Surveys).
l Stabilisation in recent and reduction in current prevalence of illicit drugs in 15-24 year old 
population (Drug Prevalence Survey).
l Stabilisation in recent and reduction in current prevalence of illicit drugs in 15-24 year old 
population (Drug Prevalence Survey).
l Prevalence of children living with parental substance misuse (GUI survey (Growing up 
in Ireland), NACDA research on children living with parental substance misuse).
l Identify the number of children who come to the attention of child protection services 
as a result of parental substance misuse (Children in Care dataset, HSE).
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CHAPTER 4 – Goal 2: Minimise the 
harms caused by the use and misuse 
of substances and promote rehabilitation 
and recovery
Introduction
Problem substance use is a chronic, often recurring condition that can cause substantial harm 
to the person concerned. As a result, recovery is often seen as a journey, and rehabilitation as 
a process, that supports and encourages the individual at each stage along the pathway to 
recovery. Recovery is a personal matter. A successful outcome or improvement for one person 
may involve improving their quality of life and overcoming reliance on their primary drug of 
dependence. For another person, the ultimate goal for their own recovery may be to become 
drug free. In order to promote recovery and minimise the harms caused by substance misuse, 
timely access to appropriate services relevant to the needs and circumstances of the person 
concerned is of fundamental importance.
Objective 2.1: To attain better health and social outcomes 
for people who experience harm from substance misuse 
and meet their recovery and rehabilitation needs
Continuum of care model
The HSE has developed a 4-tier person-centred model of rehabilitation based on the principle 
of a “continuum of care” that allows the individual to access the range of supports they need 
to achieve their personal recovery goals in line with their needs and aspirations 28. This model 
of care is designed to enable people to receive the support they need as close to home as 
possible, and at the level of complexity that best corresponds to their needs and specific 
circumstances. The various types of intervention and the settings in which they are provided are 
set out in Figure 6 below.
Information, advice and referral interventions are provided through Tier 1 of the model. Tier 
1 interventions also include the type of social reintegration and rehabilitation support and 
wraparound services that a person may need following specialist treatment provided in Tier 3 or 
Tier 4 settings. These interventions are made available through an integrated system of support 
that includes education and training, employment, housing, family support, general health and 
other services.
Tier 2 includes harm reduction support, which may be provided by a pharmacy or in a 
community setting, and also includes some specialist addiction services. Many of these 
services are provided by agencies which adopt a low threshold approach, meaning that the 
requirements to access these services are kept to a minimum.
In Tier 3 treatment and rehabilitation services provide specialist interventions in a range of 
settings dedicated to this purpose.
Specialised and dedicated inpatient or residential units or wards provide Tier 4 interventions, 
which include inpatient detoxification, sometimes linked to residential rehabilitation units, or 
assisted withdrawal and stabilisation.
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Figure 6: The Four Tier Model of Care
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The recognition that no one service can cater for the diverse needs of the service user is key to 
improving health and social outcomes for people who experience harm as a result of substance 
misuse. Case management aims to increase engagement with different services and to achieve 
common goals through providing an integrated care pathway for the service user. Evidence 
suggests that it is an effective approach to retaining people in treatment.
The HSE has developed a National Drugs Rehabilitation Framework 29 (NDRF) which 
acknowledges that the integrated care pathway is the shared responsibility of a range 
of agencies. These may include education, training and employment, health, welfare and 
housing sectors, depending on the circumstances of the individual concerned. The framework 
contains broad national protocols to facilitate inter-agency working, covering issues such as 
confidentiality, common assessment tools, referral procedures and conflict resolution between 
agencies.
As part of the NDRF, the HSE has devised a structured and evidence based model of screening 
and brief intervention that is undertaken prior to the key working, care planning and case 
management phases of service provision. It enables an initial assessment to be made in relation 
to problem alcohol and substance use in order to intervene early with at-risk groups in a variety 
of settings and refer the person on to relevant services as appropriate.
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The HSE has also developed a series of training programmes on the NDRF, including an online 
training package on key working and care planning, aimed at drug and alcohol services, and 
homeless services involved in the rehabilitation process. The intention is to expand this training 
to a range of other services and settings in order to achieve integrated case management, 
seamless transition between services and optimal pathways to recovery for people who use 
addiction services. This will include training on screening and brief intervention.
Improving access to services
Ensuring timely access to health and social care services and extending the range of treatment 
options available is integral to achieving better outcomes. Recent evidence provides some 
indication of likely future trends and the types of challenges in the years ahead. An aging 
heroin-using cohort, the proliferation of new psychoactive substances, polydrug use and the 
changing geographic and demographic profile of the drug problem are among the issues that 
will contribute to the demand for services under this strategy.
Drug treatment services have been expanded throughout the country over the past decade to 
respond to a rising demand for drug treatment. Much of this expansion has concentrated on 
improving access to opioid substitution treatment (OST) and harm reduction initiatives, such 
as needle exchange programmes, outside Dublin, especially in areas of the country that have 
experienced opioid problems more recently. Community-based drug projects have contributed 
towards expanding the network of services by delivering an integrated holistic service on the 
ground in their communities on behalf of statutory agencies.
In the past ten years, the number of residential beds has increased significantly, largely due 
to the increased provision of beds in community-based residential facilities. The most recent 
figures available (including private provision) estimate current provision at 787 residential beds, 
comprising 23 inpatient unit detoxificiation beds, 117 community-based residential detoxification 
beds, 4 adolescent residential detoxification beds, 625 residential rehabilitation beds and 18 
adolescent residential beds.
The rising demand for drug treatment is evident in the treatment figures in the past decade 11. 
The numbers of new treatment cases, excluding alcohol, increased from 2,278 to 3,742 between 
2006 and 2015 30. The most notable changes were in the numbers of new cases treated for 
problem cannabis use, which rose rapidly in the time period, and for benzodiazepines, which 
rose steadily between 2008 and 2014, with a small decrease recorded in 2015.
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Figure 7: New treatment cases by drug type 2006-2015
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Ireland remains a country with a relatively large opiate problem, and although the 
characteristics of this group are changing, they remain a key target for drug treatment services. 
Since 2009, the HSE has provided wider access to Opioid Substitution Treatment (OST) around 
the country. This has been achieved through the establishment of new treatment centres, the 
participation of more GPs in the prescribing of OST and the involvement of more pharmacies in 
the dispensing of methadone.
Reflecting the wider availability of OST, the number of clients in receipt of OST as of 31st 
December each year increased steadily from 7,260 in 2005 to 10,087 in December 2016. At the 
end of December 2008, there were 5,181 patients attending clinics, with a further 452 receiving 
OST in prison. At the end of December 2016, the figures were 5,438 and 465 respectively. 
Within a GP setting there have been even greater increases. At the end of December 2008, 
there were 3,085 patients receiving OST in GP settings, which had increased to 4,184 at the end 
of December 2016 (an increase of more than 35%) 31.
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Figure 8: Numbers in OST treatment by provider
0 
1000 
2000 
3000 
4000 
5000 
6000 
Clinics GPs Prison
Total at end of Dec 2008 Total at end of Dec 2016
Data Source: Data provided by the Central Treatment List
Despite improvements in service provision, people report having to travel a significant distance 
to access more specialist treatments, especially in rural areas. The time involved, the cost 
of travel, the need for childcare or the absence of a support network can result in barriers 
to accessing treatment for some people, even when there are financial supports available. 
Difficulties in accessing OST also include a lack of local services and waiting times. A range 
of options will therefore be explored to facilitate wider access to OST in the community. This 
includes measures to involve more GPs in prescribing OST, an examination of the feasibility 
of nurse-prescribing of OST and the provision of OST in a wider range of settings, such as 
community-based initiatives or homeless services.
In conjunction with the Irish College of General Practioners, the HSE is working to increase 
engagement of all GPs who are trained at Level 1 and Level 2 throughout the country. Level 1 
training provides the foundation for treating stable methadone maintained patients. Having 
successfully managed a number of patients for at least one year and having completed an 
external clinical audit, a GP may progress to Level 2. A Level 2 GP may initiate treatment, 
stabilise doses and provide ongoing maintenance treatment to a drug user in the primary care 
setting. Ideally all stable methadone patients who are registered with a Level 1 GP should be 
transferred to their own GP, where appropriate, provided their own GP has Level 1 training.
People who are dependent on opiates, are engaged in high risk drug use such as injecting, 
or who are using multiple substances can also experience barriers to accessing treatment, 
especially residential treatment 11. At the end of 2014, there were 9,764 people availing of OST. 
The national prevalence estimate of opiate users in 2014 was between 18,720 and 21,454, which 
would suggest that there is a considerable number of people who use opiates not currently in 
treatment 7. All the participants in a 2009 Irish study on sex work 32, had a history of injecting 
drug use and half reported recently injecting drugs. This highlights the need for an effective 
response for those with complex interlocking needs.
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Some residential services do not have the appropriate level of clinical governance to respond to 
those with more complex needs, and may have entry thresholds in place which exclude those 
who have more unstable patterns of drug use. Standardising referral processes and lowering 
the entry criteria for accessing residential treatment services, while ensuring appropriate levels 
of clinical governance, would make it easier for people with more complex needs to access 
treatment. The development of residential services that can cater for the needs of those who 
use a variety of substances will be particularly important in this context.
It is also intended to improve treatment choices for people who are not clinically suited to 
methadone treatment, but require medication-assisted therapy to address dependence on 
opiates. There is a commitment in the 2017 HSE Service Plan to provide wider access to 
alternative OST products containing buprenorphine or buprenorphine/naloxone.
The National Clinical Effectiveness Committee (NCEC) Standards for Clinical Practice Guidance 
(2015) promote consistency of approach for the development of guidelines and guidance such 
as policies and protocols. These NCEC National Clinical Guidelines and National Clinical Audit 
endorsed by the Minister for Health are mandated for implementation in the Irish health system 
and their implementation will be monitored through HSE Performance Assurance Reports, 
compliance with the National Standards for Safer Better Healthcare and increased alignment 
with the Clinical Indemnity Scheme.
The HSE has published national clinical guidelines for OST to ensure that the quality and safety 
of care to the patient is maintained and improved where necessary. The HSE will implement 
these guidelines until National Clinical Effectiveness Committee guidelines are in place 31.
Mapping the range of services currently available against underlying need in order to identify 
gaps in provision across the country will help to ensure that there is an appropriate mix of 
quality services to respond to changing trends and patterns of drug use, including the rising 
demand for treatment for cannabis-related problems. It will also be important to continue 
developing the capacity of services to respond to those with more complex needs, including 
vulnerable groups, such as Travellers or those affected by homelessness, or those with more 
high-risk behaviours or patterns of use.
No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.12 Strengthen the 
implementation of 
the National Drugs 
Rehabilitation 
Framework.
a) Developing a competency 
framework on key working, care 
planning and case management; 
and
b) Extending the training 
programme on the key 
processes of the National Drugs 
Rehabilitation Framework.
HSE
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.13 Expand the availability 
and geographical spread 
of relevant quality drug 
and alcohol services and 
improve the range of 
services available, based 
on identified need.
a) Identifying and addressing gaps 
in provision within Tier 1, 2, 3 and 
4 services;
b) Increasing the number of 
treatment episodes provided 
across the range of services 
available, including:
l  Low Threshold;
l  Stabilisation;
l  Detoxification;
l  Rehabilitation;
l  Step-down;
l  After-Care;
c) Strengthening the capacity of 
services to address complex 
needs.
HSE C&V 
sectors, 
DATFs
2.1.14 Improve the availability 
of Opioid Substitution 
Treatments (OSTs).
Examining potential mechanisms to 
increase access to OSTs such as the 
expansion of GP prescribing, nurse-
led prescribing and the provision of 
OSTs in community-based settings 
and homeless services.
HSE DOH
2.1.15 Enhance the quality 
and safety of care in 
the delivery of Opioid 
Substitution Treatment 
(OST).
Implementing the HSE National 
Clinical Guidelines on OST and 
reviewing in line with National Clinical 
Effectiveness Committee processes.
HSE DOH
Promoting recovery by improving access to services for specific groups 
of people
The location of services is only one barrier to accessing treatment. Some people may face 
additional barriers to accessing treatment because of their own personal circumstances or 
because they belong to a particular group or community. In addition, some people do not have 
the internal and external resources needed to achieve and maintain recovery from substance 
misuse, as well as make behavioural changes. Internal resources may include their resilience, 
whereas external resources may be their social networks, family or community supports. 
These resources are also referred to as “recovery capital” 33.
Helping individuals to build their recovery capital is at the heart of the continuum of care model, 
which is centred on the individual and their needs at each stage in their personal recovery 
pathway. A variety of elements can support or jeopardise recovery; these include social 
networks, physical, human, cultural and community issues. In the circumstances, developing 
social, educational and employment skills should form a key part of individual care plans.
Building a sustainable network of positive relationships contributes to developing recovery 
capital. Families can provide practical and emotional support to the person in recovery and 
reinforce the beneficial effects of positive social networks. Reconciliation services can support 
those who wish to re-establish links with families from whom they have been estranged. Self-
help, mutual aid and peer support can also be beneficial to help build positive social networks 
that support people in sustaining their recovery.
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Community Drug Projects play an important role in building recovery capital by delivering an 
integrated holistic service on the ground in their communities in partnership with statutory 
agencies. They are well placed to adapt and respond to the changing needs of service users, 
their families and the wider community. A rehabilitation project based in Dublin’s north-inner 
city is a good example of a community-based interagency initiative. It provides a structured 
assets-based programme of learning and development which gives educational opportunities 
to people in recovery who may have left school at a young age.
The contribution that a job can make to progressing and maintaining recovery is well 
established 34. The Department of Social Protection’s (DSP) Community Employment 
Programme aims to support the development of personal and employment skills and act as 
the labour market element in the Continuum of Care. This programme allocates 1,000 places to 
people in recovery through a number of dedicated Drug Rehabilitation CE schemes. Building on 
the key role of Community Employment (CE) in relation to the rehabilitation, progression and 
reintegration into society of recovering drug users, the implementation of the DSP Programme 
Framework for CE Drug Rehabilitation Schemes will be monitored under this strategy to 
improve overall progression rates.
Often a number of issues need to be addressed before individuals can progress to activation 
and job search. Therefore, undertaking wellbeing/self-esteem/confidence building work is often 
a starting point for progression towards employment or further education. The Social Inclusion 
and Community Activation Programme (SICAP), which is overseen and managed by Local 
Community Development Committees (LCDCs) in each local authority area, supports individuals 
and marginalised target groups experiencing educational disadvantage or unemployment so 
they can participate fully, engage with and progress through life-long learning opportunities 
through the use of community development approaches. SICAP programme implementers 
engage with participants on a one-to-one basis and agree a personal action plan. SICAP 
supports include educational supports, labour market training and occupational specific skills, 
career advice and guidance support, employment supports and self employment supports 
which assist in moving individuals closer to or into the labour market, which has a positive 
effect on the individuals, their families and the wider community. During 2016, 55,890 children 
received educational and/or developmental support under SICAP, of which, 782 were identified 
as being at risk of early school leaving and a further 5,373 young people aged between 15 and 
24 years old who were not in employment, education or training were also supported.
Poverty, deprivation and inequality contribute to the vulnerability that may lead to dependency 
and harm and act as barriers to recovery and leading a fulfilling, safe and healthy life. Those 
who have completed treatment programmes will continue to need access to aftercare services 
and other progression options to enable them to sustain recovery. These options may include 
educational support, personal development, training and employment opportunities, as well as 
continued access to peer-support. In order to help such groups maintain their recovery, it will 
be necessary to increase opportunities for their progression. Identifying and remedying any 
barriers to accessing such supports will be important in this context.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.16 Improve relapse 
prevention and 
aftercare services.
Developing and broadening the range 
of peer-led, mutual aid and family 
support programmes in accordance 
with best practice.
HSE C&V sectors, 
UISCE, NFSN
2.1.17 Further strengthen 
services to support 
families affected by 
substance misuse.
a) Developing addiction specific 
bereavement support 
programmes and support 
the provision of respite for family 
members;
b) Supporting families with 
non-violent resistance training to 
address child to parent violence; 
and
c) Supporting those caring for 
children/young people in their 
family as a result of substance 
misuse to access relevant 
information, supports and 
services.
TUSLA HSE, NFSN
2.1.18 Help individuals 
affected by 
substance misuse to 
build their recovery 
capital.
a) Monitoring and supporting 
the implementation of the 
Department of Social Protection’s 
Programme Framework for 
Community Employment Drug 
Rehabilitation Schemes, based 
on an integrated inter-agency 
approach; and
b) Utilising SICAP to improve the 
life chances and opportunities 
of those who are marginalised 
in society, living in poverty 
or in unemployment through 
community development 
approaches, targeted supports 
and interagency collaboration.
DSP
 
 
 
 
 
 
 
DHPLG
HSE
Other 
relevant 
Departments 
& Agencies, 
C&V sectors
2.1.19 Increase the range of 
progression options 
for recovering drug 
users and develop a 
new programme of 
supported care and 
employment.
Establishing a Working Group to:
a) Examine the range of 
progression options for 
those exiting treatment, prison, 
Community Employment 
schemes including key skills 
training and community 
participation with a view to 
developing a new programme of 
supported care and employment; 
and
b) Identify and remedy the 
barriers to accessing the 
range of educational, personal 
development, training and 
employment opportunities 
and supports, including gender 
specific barriers and the lack 
of childcare provision, for 
those in recovery.
DOH HSE, DSP, 
IPS, Other 
relevant 
Departments 
& Agencies
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Improving access to services for women, children and young people
Women
Women can experience barriers to engaging and sustaining involvement with treatment and 
rehabilitation services. Many women in addiction have experienced domestic violence (in their 
family of origin and/or in intimate partner relationships) and services should be equipped to 
respond appropriately to this issue. There is a need for greater awareness of the implications 
of domestic violence, trauma and mental health for treatment and rehabilitation of women 
with addictions.
The absence of childcare can be a barrier for women attending treatment and after-care 
services. While there are good examples of wrap-around services for female drug-users in 
recovery and their children, there is only one residential treatment service located in west 
Dublin, where mothers can keep their babies with them during treatment. There is a need to 
increase the range of wrap-around services and supports to facilitate more women with children 
or who are pregnant taking up treatment.
There are currently three Drug Liaison Midwives, with each attached to one of the three Dublin 
maternity hospitals (the Rotunda, the National Maternity Hospital and the Coombe Women & 
Infants University Hospital). They are employed by the Addiction services and work in special 
clinics in each of the hospitals. The Drug Liaison Midwives see pregnant opioid dependent 
women in their clinics, support them throughout their pregnancy and for six weeks post-natal. 
They can arrange for inpatient detoxification or stabilisation if necessary and have contributed 
significantly to reducing stigma and harm to this vulnerable group of patients.
A study in the Coombe Women & Infants University Hospital 35 in Dublin showed that 4.6% 
of women who registered for care reported using drugs during pregnancy, the vast majority 
of which related to methadone. These women have complex medical and social needs and 
are at an increased risk of having babies with low birth weights and other complications. 
Their involvement with the maternity services provides an opportunity to reduce their drug 
dependence and improve their social circumstances and wellbeing.
While recent years have seen a decrease in the number of opiate dependent women attending 
these services, there are concerns about alcohol use during pregnancy. A 2017 Lancet study 
36 found that, of the 50 countries for which data were available, Ireland was one of the five 
countries with the highest prevalence of alcohol use during pregnancy.
A National Women & Infants Health Programme (NWIHP) has been established within the HSE 
to lead the management, organisation and delivery of maternity, gynaecological and neonatal 
services across primary, community and acute care. The National Maternity Strategy 37 made 
the following recommendations regarding alcohol and drugs misuse:
l The NWIHP will examine the need to provide drug liaison midwives and specialist medical 
social workers in all maternity networks;
l Maternity hospitals/units will strengthen their methods of detecting alcohol abuse and 
supporting women to reduce their intake; and
l The NWIHP will develop a consistent approach to informing women about the risks of 
alcohol consumption during pregnancy.
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Children and young people
The National Substance Misuse Strategy 9 highlighted the need to expand services for people 
under 18 years of age who are experiencing problems as a result of using substances. Most 
young people can be treated in the community, but some will need more specialised services, 
including residential rehabilitation and detoxification facilities. Many young people with 
substance use issues may also be experiencing mental health problems which need to be 
addressed as part of their treatment. The Youth Drug and Alcohol Service (YoDA) based in west 
Dublin provides assistance and treatment to those under 18 who are having problems related to 
their drug or alcohol use. A 2013 study of users of the service 38 found that 48% had a lifetime 
history of psychiatric disorders, with deliberate self-harm being the most common condition.
No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.20 Expand addiction 
services for pregnant 
and postnatal women.
a) Strenghtening links between 
maternity services and addiction 
services;
b) Quantifying the need for 
additional residential placements 
for pregnant and postnatal 
women who need in-patient 
treatment for addiction to 
drugs and/or alcohol across the 
country;
c) Developing services to meet that 
need ensuring that such facilities 
support the development of the 
mother-baby relationship;
d) Providing dedicated support for 
pregnant women with alcohol 
dependency, including examining 
the need to expand the role 
of the Drug Liaison Midwife 
(DLM) in this regard. Any such 
expansion will likely generate 
a need to further increase the 
number of such midwives;
e) Resourcing the National Women 
and Infants Health Programme 
(NWIHP) to provide drug liaison 
midwives and specialist medical 
social workers in all maternity 
networks;
f) Supporting maternity hospitals/
units to strengthen their methods 
of detecting alcohol abuse and 
supporting women to reduce 
their intake; and
g) Engaging the NWIHP to develop 
a consistent approach to 
informing women about the risks 
of alcohol consumption during 
pregnancy.
DOH HSE
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.21 Respond to the needs 
of women who are 
using drugs and/or 
alcohol in a harmful 
manner.
a) Increasing the range of wrap-
around community and 
residential services equipped to 
meet the needs of women who 
are using drugs and/or alcohol in 
a harmful manner, including those 
with children and those who are 
pregnant; and
b) Developing interventions to 
address gender and cultural 
specific risk factors for not taking 
up treatment.
HSE DOH, 
DATFs
2.1.22 Expand the range, 
availability and 
geographical spread 
of problem drug and 
alcohol services for 
those under the age of 
18.
a) Identifying and addressing gaps 
in child and adolescent service 
provision;
b) Developing multi-disciplinary 
child and adolescent teams; and
c) Developing better interagency 
cooperation between problem 
substance use and child and 
family services.
HSE, 
TUSLA
C&V 
sectors, 
DATFs
Improving access to services for people with more complex needs
There is a need to recognise the diversity evident among drug users and to take steps in 
providing services that can accommodate this diversity and address the needs of particular 
groups in relation to problem drug and alcohol use. Specific groups with more complex needs 
include:
l Long-term substance users;
l People with co-morbid mental health and substance use problems;
l Members of the Traveller community and other minority ethnic communities;
l Homeless people, people in prison and sex workers; and
l Lesbian, gay, bisexual, transgender and intersex communities.
The HSE is currently examining the most practical, sustainable means of supporting staff 
to deliver services in culturally competent ways in consultation with traveller representative 
organisations. Cultural competence is defined as the ability of service providers and 
organisations to effectively deliver health care services that meet the social, cultural and 
linguistic needs of those who use services. Service-delivery staff should uphold fundamental 
values and attitudes (such as equality, empathy and engagement) towards all service users.
Long-term substance users
The number of people who are older and availing of treatment for heroin use is increasing 39. 
Over 40s comprised 42% of OST clients in 2015, up from 31% of clients in 2013. This cohort 
is likely to suffer from negative social consequences of long term drug use such as 
unemployment, social exclusion, marginalisation and homelessness. In addition to conditions 
associated with the normal aging process they are prone to a range of health-related problems 
including dental deterioration, hepatic damage, often exacerbated by excess alcohol use, and 
chronic lung, venous and arterial damage. They are also at risk from harm as result of the 
interactions between methadone and medications used to treat other diseases.
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People with a co-occurring mental health and substance use problem
A recurring theme in the public consultation was a concern about access to services for 
people who have a co-occuring mental health and substance use problem, often called “dual 
diagnosis”. Ensuring that people with a dual diagnosis receive an assessment, an onward referral 
and timely access to appropriate treatment is extremely important. They may be dealing with 
the impact of trauma or a psychiatric disorder as well as experiencing problems as a result of 
alcohol and/or drug use. These individuals may also have physical and psychological health 
problems, disabilities, or problems with housing, employment and relationships or have a 
history of offending.
The HSE’s Mental Health Division is working with the Clinical Strategy and Programmes Division 
to develop a new Mental Health Clinical Programme called “Dual Diagnosis: mental illness 
and co-morbid substance misuse”. The aim of this Programme is to develop a standardised 
evidence-based approach to the identification, assessment and treatment of co-morbid mental 
illness and substance misuse. This includes increasing awareness of the frequent coexistence of 
mental illness and substance misuse; ensuring there is a clear clinical pathway for management 
of people with such a dual diagnosis, including when they present to Emergency Departments; 
ensuring a standardised service is provided throughout the country; and ensuring adolescents 
are also included within the scope of this Clinical Programme.
An integral part of the Dual Diagnosis Programme will be to devise a model of care that will 
ensure that all adolescents and adults suspected of having a moderate to severe mental illness 
coexisting with significant substance misuse have access to a timely mental health service 
delivered on a regional basis. The service will be provided in an integrated manner across 
the Primary Care Division and the Mental Health Service. There will also be close working 
relationships with the relevant specialities in Acute Hospitals to deal with any medical co-
morbidities that may occur, particularly in those with alcohol misuse.
People who are homeless
People who are homeless are at a far higher risk of problem drug use than people in secure 
housing, with particularly high levels of use and risk amongst rough sleepers and those using 
emergency accommodation. While substance misuse can lead to homelessness, homelessness 
can also contribute to the development of substance misuse problems. This underlines the 
importance of homelessness services and substance misuse services working together in a 
collaborative way, such as through the nine regional homelessness forums 40. Although a lack 
of housing is currently a society-wide issue, providing independent tenancies to homeless 
people with appropriate supports offer the best outcomes for individuals that have successfully 
completed treatment and rehabilitation.
In Rebuilding Ireland: Action Plan for Housing and Homelessness 41, the Government committed 
to a tripling of the target for tenancies to be provided. Housing led/housing first programmes, 
which provide for accommodation with supports as required, are internationally considered as 
best practice in addressing the needs of people who are long-term homeless and with complex 
needs. The success of such initiatives depends not just on housing but also, crucially, on drug 
and alcohol, mental health, and community integration services being available.
People in contact with the criminal justice system
Prisoners
Lifetime prevalence of cannabis, cocaine and heroin is at a far higher rate among prisoners than 
in the general population and notably female prisoners report higher lifetime and past month 
use of heroin and both crack and powder cocaine 42. Between 2009 and 2015, 5,450 cases 
received treatment in prison. This represents more than 9% of the total treatment cases in the 
country during this period.
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There is a range of drug rehabilitation programmes available for prisoners that involve a 
significant multidimensional input by a diverse range of general and specialist services 
provided both by the Irish Prison Service (IPS) and visiting statutory and non-statutory 
organisations 43. The programmes seek to reduce the demand for drugs within the prison 
system through education, treatment and rehabilitation services for prisoners with addictions. 
Particular initiatives include the provision of detoxification, methadone maintenance, education 
programmes, addiction counselling and drug therapy programmes. The delivery of these 
services is being achieved in partnership with community-based services and has brought a 
significant improvement in the range, quality and availability of drug treatment services in the 
prisons.
The IPS continues to work to decrease the availability and use of illicit drugs in the prison 
environment. These efforts will need to take into consideration the challenges posed in 
responding to the newer drugs of choice, in particular, new psychoactive substances, in 
the prison environment. These newer drugs will require more contemporary and advanced 
strategies to meet the physical, procedural and related security requirements.
The IPS is committed to providing healthcare, including specialist addiction services, to 
those in custody on an equivalent basis to that available to the general population. It remains 
important that particular attention continues to be paid to identifying risk factors as a result of 
drug use and to providing the necessary drug treatment services to support positive changes 
in behaviour. Ensuring that people leaving prison can continue to access treatment in the 
community is essential and continues to be one of the key objectives of the National Drugs 
Rehabilitation Framework.
People engaged with Probation Service
There is a clear association between substance misuse and offending behaviour. Substance 
misuse is harmful to the individual and can lead to an increase in criminal activity, causing harm 
and victimisation in communities. Where this is the case, the importance of access to targeted 
substance misuse interventions for those subject to criminal justice sanctions in the community, 
such as probation supervision, can provide an opportunity to support and effect change in the 
lives of these individuals and their communities.
Improving access to services for specific populations
Members of the Travelling community
Poor living conditions and high levels of unemployment and educational disadvantage 
contribute to the higher risk of drug and alcohol misuse among members of the Travelling 
community. While Travellers represent just over one half per cent of the population, 3.6% of 
those treated for problem drug use in 2015 were from the Travelling community 30. Compared 
to the general population, the main problem drug reported by Travellers accessing treatment 
between 2007 and 2010 was more likely to be opiates (37% vs 29%). During the same period 
there was an increase in the number of Travellers seeking treatment for benzodiazepines and 
cannabis and this was above the rate of increase in the general population. The prevalence of 
main problem drugs were similar for male Travellers as the general population, but amongst 
female Travellers, opiates were reported more frequently as the main problem drug.
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Although male Travellers entering drug treatment were less likely to have lifetime prevalence 
of injecting drug use compared to the general population, female Travellers reported higher 
rates of injecting; 24% compared to 16% in the general population. Travellers entering drug 
treatment were more likely to report polydrug use, with cannabis the most frequently reported 
second problem substance 11. Good practice guidelines, produced on behalf of this community, 
provide useful and practical advice on supporting Travellers who need to use treatment 
services.
Other groups with complex needs
The LGBTI community are another group which face higher risks of problem substance use. 
A recent national study reports that recreational drug use amongst LGBTI is two times higher 
than in the general population 44. Over 50% of LGBTI people have taken drugs recreationally, 
with cocaine-based drugs and ecstasy being the most common drugs used.
Migrant communities may also experience barriers to accessing services or maintaining 
treatment, for a variety of reasons. Marginalised members of society and hard to reach groups 
may need targeted interventions, as equality of access does not always result in quality of 
participation or of outcomes.
No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.23 Improve the response 
to the needs of older 
people with long term 
substance use issues.
Examining the need for the 
development of specialist services to 
meet the needs of older people with 
long term substance use issues.
HSE C&V 
sectors, 
DATFs
2.1.24 Improve outcomes for 
people with co-morbid 
severe mental illness 
and substance misuse 
problems.
a) Supporting the new Mental 
Health Clinical Programme to 
address dual diagnosis; and
b) Developing joint protocols 
between mental health services 
and drug and alcohol services 
with the objective of undertaking 
an assessment with integrated 
care planning in line with the 
National Drug Rehabilitation 
Framework.
HSE DOH, 
IPS, C&V 
sectors
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.25 In line with Rebuilding 
Ireland, improve the 
range of problem 
substance use services 
and rehabilitation 
supports for people 
with high support needs 
who are homeless.
a) Increasing the number of 
detoxification, stabilisation and 
rehabilitation beds;
b) Providing additional/enhanced 
assessment, key working, care 
planning and case management. 
This entails person-centred 
holistic care planning, including 
identifying and building social 
and recovery capital;
c) Ensuring in-reach support during 
treatment and rehabilitation 
to prevent homelessness on 
discharge to ensure that housing 
and supports are in place;
d) Ensuring resourcing and 
enhanced cooperation 
arrangements between non-
governmental service providers 
and State organisations, involved 
in the delivery of addiction 
treatment and housing services, 
so that the drug rehabilitation 
pathway is linked to sustainable 
supported housing-led/housing 
first tenancy arrangements; and
e) Developing the provision of 
gender and culturally specific 
step down services, particularly 
housing, for women and 
their children progressing 
from residential rehabilitation 
treatment who are at risk of 
discharge into homelessness.
HSE 
 
HSE 
 
 
 
 
 
HSE 
 
 
 
DOH
DHPLG 
 
 
 
 
 
 
 
 
 
LAs, HSE
C&V 
sectors 
LAs, C&V 
sectors
 
 
 
 
 
LAs, C&V 
sectors
 
 
 
HSE, 
LAs, C&V 
sectors 
 
 
 
 
 
 
 
DHPLG, 
DOH, 
C&V 
sectors
2.1.26 Intervene early with at 
risk groups in criminal 
justice settings.
a) Providing training to enable 
the delivery of screening, brief 
intervention and onward referral 
in line with national screening and 
brief intervention protocols for 
problem substance use;
b) Further develop the range 
of service specific problem 
substance use interventions 
in line with best international 
practice; and
c) Determining the prevalence of 
NPS use in prison settings with 
a view to developing specific 
training for staff and appropriate 
interventions.
IPS, PS 
 
 
 
 
IPS, PS 
 
 
 
IPS
AGS, 
HSE 
 
 
 
 
 
 
 
HSE
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.27 Improve the capacity 
of services to 
accommodate the 
needs of people 
who use drugs 
and alcohol from 
specific communities 
including the Traveller 
community; the 
lesbian, gay, bisexual, 
transgender and 
intersex community; 
new communities; sex 
workers and homeless 
people.
a) Fostering engagement with 
representatives of these 
communities, and/or services 
working with them, as 
appropriate;
b) Considering the need for 
specialist referral pathways for 
specific groups who may not 
otherwise attend traditional 
addiction services (i.e. those who 
engage in chemsex);
c) Providing anti-racism, cultural 
competency and equality training 
to service providers; and
d) Ensuring all services engage 
in ethnic equality monitoring 
by reporting on the nationality, 
ethnicity and cultural background 
of service users for the NDTRS 
and treat related disclosures with 
sensitivity.
HSE C&V 
sectors
Objective 2.2: Reduce harm amongst high risk drug users
People who inject drugs (PWID) are a particularly vulnerable population that are susceptible 
to harm and need carefully managed supports to enable them attain stability and a safer and 
healthier life 11. Infectious diseases are among the most serious health consequences of injecting 
drug use. Injecting drug use is one of the main modes of transmission of hepatitis C (HCV) 
infection in Ireland. The number of HCV cases reported to the Health Protection Surveillance 
Centre (HPSC), where injecting drug use was identified as a risk factor has been declining 
since 2010 when 728 such cases were reported. In 2015, 169 such cases were reported 45. 
Nevertheless, PWID make up the majority of all cases of HCV in Ireland. Chronic HCV infection 
may cause liver cirrhosis, hepatocellular carcinoma and liver failure.
HPSC data show a gradual decline in new cases of HIV amongst PWID from 2005 to 2012. 
The number of such cases began to rise in 2013 and continued to rise to 27 cases in 2014. 
In 2015, 9% (45) of newly diagnosed HIV cases were PWID. This is the highest number of 
new HIV cases among PWID recorded since 2008 45.
Ensuring access to needle exchange, harm-reduction advice promoting sexual health and 
screening programmes will continue to play an important role in reducing the risk of contracting 
blood-borne viruses such as HCV and HIV. Needle exchanges are provided in counties Dublin, 
Kildare and Wicklow by a mix of static and outreach services. The National Pharmacy Needle 
Exchange programme provides needle exchange interventions outside of these areas. At the 
end of 2016, there were 109 pharmacies participating in this programme 31. An average of 1,330 
individuals attended pharmacy-based needle exchanges each month in 2014.
Many respondents in the public consultation highlighted ease of access to prescription 
medication, particularly benzodiazepines and so-called z-drugs (zopiclone and zaleplon), 
through the internet, with direct delivery to a person’s door. This is reflected in figures for the 
last 10 years which indicated an increase in treatment demand relating to benzodiazepines, as 
well as a rapid increase in related deaths, in Ireland in comparison to other European countries. 
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The National Drug Related Deaths Index (NDRDI) indicates that prescription drugs were 
implicated in three in every four, or 259, poisoning deaths during 2014. Benzodiazepines were 
the most common prescription drug group implicated and diazepam (a benzodiazepine) was 
the most common single prescription drug implicated in 115 (32%) of all poisoning deaths in 
that period 8.
The illegal trade in so-called z-drugs, has exacerbated the problem particularly among those 
who inject drugs. The Minister for Health has amended the Misuse of Drugs Regulations to 
tighten controls on benzodiazepines and z-drugs. It will be important to ensure that the health 
needs of people, who can no longer gain access to these substances through the illegal drug 
market are addressed when such controls are in place.
There is a recognised problem with street injecting in Ireland, particularly in Dublin City 
centre. This practice poses a significant health risk for people who use drugs, and results in 
discarded needles which presents a public health risk to others. Mounting public concern 
and campaigning by harm reduction advocates led to a proposal for the establishment of 
supervised injecting facilities (SIF) to ameliorate these problems and the Programme for 
Government contains a commitment to legislate for such facilities.
On 16 May the Misuse of Drugs (Supervised Injecting Facilities) Act 2017 (No. 7 of 2017) 46 was 
signed by the President having been passed by the Oireachtas on 10 May. The Act will allow for 
the licensing and establishment of supervised injecting facilities by the Minister for Health. The 
HSE plans to establish the first SIF on a pilot basis in order to determine its utility, safety and 
cost effectiveness in an Irish context.
Risk of Overdose and Drug-Related Deaths
The Rapid Expert Review 10 noted that “drug related overdose and other forms of avoidable 
mortality associated with drug use has to be a major concern for any future drug strategy as 
it is in this area that a large share of the health costs associated with drug use are accrued and 
thus also the area where the greatest potential benefits from intervening effectively may be 
obtained”.
There is a worrying level of overdose rates in Ireland. 4,256 non-fatal overdose cases, or 
poisoning by alcohol and/or other drugs, were recorded as being admitted to Irish hospitals in 
2014. This reflected a marginal increase from 4,233 cases in 2013, but trends over time indicate 
a decrease from 2005 when there were 5,012 cases 45.
In 2014, the EMCDDA reported the mortality rate due to overdoses (poisonings) in Europe 
was estimated at 18.3 deaths per million population for people aged 15–64 47. Estimates for 
overdose mortality rates in Ireland are much higher, at 71 per million, the third highest in Europe 
after Estonia (113 per million) and Sweden (93 per million). However, caution is required when 
interpreting overdose data across the EU for reasons which include systematic under reporting 
in some countries and registration processes that result in reporting delays.
According to the latest NDRDI figures available, the total number of drug-related deaths 
rose from 505 to 697 over the period 2005 to 2014 inclusive. The NDRDI reports on poisoning 
deaths (also known as overdose) which are due to the toxic effect of a drug, or combination 
of drugs, and on non-poisonings which are deaths among people who use drugs, as a result 
of trauma or medical reasons 8.
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Figure 9: Drug Related Deaths in Ireland 2005–2014
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Deaths due to non-poisoning increased at a greater rate than poisoning deaths. Deaths due to 
poisonings remain a higher proportion of the total: the number of poisoning deaths increasing 
from 301 to 354 and non-poisonings deaths from 202 to 342, during the 10 year period. Many 
of these deaths are premature; half of all deaths in 2014 involved people aged 39 years or 
younger and three in four (523) involved males.
Alcohol was implicated in one in three drug-related deaths and remains the single most 
common drug implicated in deaths between 2004 and 2014. 59% of deaths where alcohol 
was implicated involved other drugs, mainly opiates. Three deaths per day in 2013 were alcohol 
related and one in three self harm cases during 2013 were alcohol related. Alcohol alone 
was responsible for 13% of all poisoning deaths.
The risk of overdose or death due to poisoning or fatalities caused by disease, infection or 
other effects of drug use is higher among those who inject drugs or those engaged in polydrug 
use. Opiates were the main drug implicated in deaths due to overdose. Two thirds of those who 
died in 2014 had taken a mixture of drugs. Benzodiazepines were the most common drug group 
involved in polydrug deaths.
This points to the need for overdose prevention strategies to reduce the incidence of both fatal 
and non-fatal overdose through the provision of targeted preventative responses for cohorts of 
the drug using population at higher risk of overdose. This should involve the targeting of known 
risk-periods, such as release from prison and leaving drug-treatment.
The piloting of the Naloxone Programme by the HSE between 2015 and 2016 is an example of a 
successful measure to reduce overdoses and drug-related deaths among those who use drugs. 
The pilot project was supported by voluntary service providers, the Irish Prison Service and the 
National Family Support Network. The HSE Service Plan for 2017 includes a commitment to 
further expand the Naloxone Programme to other drug users and their families 48. The HSE will 
continue to strengthen overdose prevention strategies in the coming years in order to maintain 
the focus on reducing drug-related deaths and non-fatal overdoses.
51Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
In addition, a clear ongoing association between certain types of non-poisoning deaths and 
mental health issues is emerging from the data. This points to a high level of such deaths 
involving persons experiencing both drug or alcohol misuse and mental health disorders 
(dual diagnosis). There was a 21% increase in deaths due to hanging between 2013 and 2014 
and more than two thirds (67%) of people who died as a result of hanging had a history of 
mental health illness.
Ireland’s National Strategy to Reduce Suicide “Connecting for Life” sets out a vision of an 
Ireland where fewer lives are lost through suicide, and where communities and individuals 
are empowered to improve their mental health and well-being 49.
Connecting for Life has seven goals:
1. Better understanding of suicidal behaviour
2. Supporting communities to prevent and respond to suicide behaviour
3. Targeted approaches for those vulnerable to suicide
4. Improved access, consistency and integration of services
5. Safe and high-quality services
6. Reduce access to means
7. Better data and research
This Strategy is being led by the Department of Health and involves actions assigned to the 
HSE, various Government departments and key statutory and non-statutory agencies in Ireland. 
Responsibility for monitoring and reporting systems to support the delivery of the Strategy 
has been assigned to the National Office for Suicide Prevention. The Strategy provides an 
implementation and evaluation structure to achieve each of the goals it proposes, with defined 
actions and a lead agency and key partners in place for each individual objective. It also has a 
strong partnership dimension, and aims for the coordination and implementation of the relevant 
goals and actions to generate outcomes which may not otherwise be achievable by bodies 
working in isolation.
No. Strategic Action Delivered by: Lead 
Agency
Partners
2.2.28 Continue to expand 
Harm Reduction 
Initiatives focused 
on people who inject 
drugs.
a) Expanding needle exchange 
programmes;
b) Increasing the availability 
of screening and treatment 
for blood borne viruses and 
communicable diseases; and
c) Increasing the uptake of Hepatitis 
C treatment.
HSE C&V sectors
2.2.29 Provide enhanced 
clinical support to 
people who inject 
drugs and mitigate 
the issue of public 
injecting.
Establishing a pilot supervised 
injecting facility and evaluating 
the effectiveness of the initiative.
HSE DOH, 
UISCE, 
Dublin City 
Council, 
Relevant 
Local 
Authorities, 
C&V sectors
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.2.30 Continue to target a 
reduction in drug-
related deaths and 
non-fatal overdoses.
a) Finalising HSE-led Overdose 
Prevention Strategy with a 
particular focus on implementing 
preventative measures to target 
high-risk cohorts of the drug-
using population and known 
overdose risk periods;
b) Expanding the availability of 
Naloxone to people who use 
drugs, their peers, and family 
members; 
c) Developing synergies between 
Reducing Harm, Supporting 
Recovery and other relevant 
strategies and frameworks 
in particular “Connecting for 
Life” whose primary aim is 
to reduce suicide rates in the 
whole population and amongst 
specified priority groups; and
d) Providing suicide prevention 
training to staff working with 
young people in the area of 
alcohol and substance use, in line 
with Connecting for Life.
HSE 
 
 
 
 
 
HSE 
 
 
 
DOH 
 
 
 
 
 
 
 
HSE
DOH 
 
 
 
 
 
C&V 
sectors, 
UISCE, 
NFSN, 
DATFs
 
 
 
 
 
 
 
 
HSE
DOH
Performance Indicators related to Goal 2
l % of problem drug users accessing treatment within 1 month of assessment (HSE figures).
l % of problem drug users aged under 18 accessing treatment within 1 week of assessment 
(HSE figures).
l Mental Health Clinical Programme on Dual Diagnosis and Joint Protocols between Mental 
Health services and Drug and Alcohol services in place (HSE figures).
l % of successful exits from treatment in a given year (NDTRS).
l % of problem substance users who have an agreed care plan (HSE figures).
l Number of people who received NDRF training (HSE figures).
l Reduction in the number of drug-related poisonings by 2020, as compared with 2016, 
based on latest data available in the reference period (NDRDI).
l Reduction in the number of deaths where opiates are implicated (NDRDI).
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CHAPTER 5 – Goal 3: Address the harms 
of drug markets and reduce access to 
drugs for harmful use
Objective 3.1: Provide a comprehensive and responsive 
misuse of drugs control framework which ensures the 
proper control, management and regulation of the 
supply of drugs
Protecting the public from dangerous or potentially dangerous and harmful substances, 
while facilitating the safe use of certain controlled substances, which though harmful if misused, 
have medical and therapeutic value, is a core objective of Ireland’s drug control framework. 
In line with our obligations under the international UN conventions, Ireland adopts a balanced 
approach to the drug problem, based on protecting public health, while engaging in national 
and international cooperation aimed at combating transnational organised crime and drug 
trafficking.
Ireland’s law enforcement agencies play a vital role in enforcing drug laws and in the national 
effort to stem the flow of potentially harmful substances entering the illegal drug market. 
An Garda Síochána, Revenue’s Customs Service, the Naval Service and the Health Products 
Regulatory Authority work together to protect public health and safety from the harms of 
the illegal drug market.
Ireland’s misuse of drugs legislation provides for different levels of control of substances based 
on their health risk, potential for misuse and validity of legitimate use. Under Irish legislation, 
unless expressly allowed to do so, it is illegal to possess, supply, manufacture, import or export 
a controlled substance. Precursor chemicals which can be used in the illegal manufacture of 
narcotic drugs and psychoactive substances are controlled through an EU legislative framework.
The Misuse of Drugs legislation provides for criminal offences and penalties for these offences, 
including possession of drugs for personal use. There is a need to keep this legislation under 
review to respond to the changing drugs situation.
2016 was a significant year in the evolution of global policy on the drug problem. The UN 
General Assembly convened a special session on drugs in New York in April 2016 50. This 
conference was an important milestone in achieving the goals set out in the 2009 Political 
Declaration and Plan of Action on International Cooperation towards an integrated and 
balanced strategy to counter the world drug problem.
Ireland participated at UNGASS as a member state of the EU and supported the key strategic 
position of the EU on drugs policy, which welcomes a steady transition towards a more 
balanced global approach that includes aspects of public health based policies, while continuing 
to pursue efforts to counter transnational organised crime and drug trafficking.
New Psychoactive Substances (NPS)
The increased availability of new psychoactive substances (NPS) has been a matter of public 
concern over the past decade. From 2007/08 onwards, there was a proliferation of headshops 
in Ireland selling a wide range of substances which, while not then illegal under the Misuse of 
Drugs Acts, were presenting potential serious health risks for users. Many of these products, 
although often marketed as bath salts or plant food and not for human consumption, were 
clearly being sold for the purposes of being consumed for drug-like effects.
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In tandem with education and awareness measures, the Government initiated a multi-pronged 
approach to targeting the activities of head shops and the sale of unregulated psychoactive 
substances and there were related actions in the 2009-2016 strategy 2.
In May 2010, the Government made an order declaring approximately 200 psychoactive 
substances to be controlled drugs for the purposes of the Misuse of Drugs Acts and the 
Minister for Health introduced the necessary regulations to control these substances. These 
instruments, which made the possession and supply of the substances concerned subject to 
criminal sanctions under the Misuse of Drugs Acts, covered most substances then commonly 
being sold in head shops. Since that time, more than 260 NPS have been controlled under 
Misuse of Drugs regulation.
Experience has shown that new psychoactive substances can quickly emerge and there will 
always be a time lag before such new substances can be made subject to control under the 
Misuse of Drugs Acts. For that reason, the Government also decided in May 2010 to introduce 
the Criminal Justice (Psychoactive Substances) Bill as a general criminal justice measure to deal 
with new psychoactive substances as they emerge on the drug market. The Bill was drafted as 
a matter of priority and was signed into law on 14 July 2010. The Act 5 came into operation on 
23 August 2010.
The Criminal Justice (Psychoactive Substances) Act 2010 5 makes it a criminal offence to sell, 
import or export, for human consumption, a psychoactive substance which is not regulated or 
controlled under other legislation.
Drug Driving
Driving under the influence of drugs is a problem in Ireland, as it can impair ability to drive. 
The Medical Bureau of Road Safety (MBRS) found that out of the 9,734 specimens of blood 
and urine tested for the presence of a drug or drugs between the years 2009 and 2015, 6,232 
or 64% tested positive 51. The Road Traffic Act 2016 64 gives An Garda Síochána new powers 
to test drivers for drugs at the roadside and in Garda stations. Current provisions for Mandatory 
Alcohol Testing (MAT) checkpoints will be extended to provide for Mandatory Intoxication 
Testing (MIT) checkpoints testing drivers for both alcohol and drugs. The new measures 
commenced on 13th April 2017. The Road Safety Authority has recently launched a campaign 
to increase awareness of the new measures which will include an ad campaign, a social media 
campaign and updated leaflets on drugs and driving and taking medicines while driving.
Strategic Review of Penal Policy
The Final Report of the Working Group on a Strategic Review of Penal Policy of July 2014 52 
contains recommendations in relation to the extension of Restorative Justice Programmes, 
the Adult Caution Scheme and Mandatory Minimum Sentencing. This report, which is currently 
being implemented, will deal with criminal behaviour including drug offending behaviour. 
Developments in relation to the implementation of the report will be monitored under the 
new strategy.
An inter-agency Working Group on Alternatives to Prosecution was established by the Criminal 
Justice Strategic Committee (CJSC) on foot of separate recommendations from the Penal 
Policy Review and the Garda Inspectorate that consideration be given to extending the scope 
of the Adult Caution Scheme. The Inspectorate had further recommended that drug possession 
offences be specifically considered for inclusion in this Scheme. In its final report to the CJSC, 
the Working Group recommended (inter alia) the extension of the Scheme to encompass 
first-time offences involving possession of a controlled substance for personal use (‘simple 
possession’). This recommendation is currently under consideration by the relevant authorities 
and a decision is expected shortly.
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Spent Convictions
The Criminal Justice (Spent Convictions and Certain Disclosures) Act 2016 65 provides for 
certain convictions to become spent once 7 years has passed since the date of conviction. 
The purpose of the legislation is to provide that persons who have made a mistake by 
committing a minor offence in the past and paid the price, can move on with their lives after 
the appropriate time and will not be held back. In accordance with the provisions of the Act 
the following convictions will be spent:
l All convictions in the District Court for motoring offences which are more than 7 years 
old will be spent, with the proviso that spent convictions for dangerous driving are limited 
to a single conviction.
l All convictions in the District Court for minor public order offences which are more than 
7 years old will be spent.
l In addition, where a person has one, and only one, conviction (other than a motoring 
or public order offence) which resulted in a term of imprisonment of less than 12 months 
(or a fine) that conviction will also be spent after 7 years. This provision will apply to 
either a District Court or Circuit Court conviction.
It should be noted that serious offences, including most importantly criminal actions directed 
against children and vulnerable persons, are not within the scope of the Act.
The Act was commenced in full on 29th April 2016. The Steering Committee is of the view that 
the operation of the Act should be reviewed after a period in operation to ensure that pathways 
to rehabilitation and a normal life for those who have committed offences during a period of 
drug use are not unduly affected by the system of recording of convictions. It was noted by the 
Steering Committee that the Act will be liable for post-enactment scrutiny at the discretion of 
the Justice & Equality Committee under the new Dáil procedures.
Sanction Options
Within the Criminal Justice System there are a range of options available to the Court in 
dealing with those who have committed a criminal offence. The legislature generally sets the 
maximum sentence that can be imposed within the drugs legislation and it is then a matter for 
the judiciary to decide what is the appropriate sentence in a particular case taking into account 
all the circumstances surrounding the crime and the individual offender. The range of options 
available to the Court in dealing with drug offences can include fines, custody, imposition of a 
Peace Bond/Probation Order, suspended sentence etc.
Drug Treatment Court
Ireland also provides for a drugs treatment court to assist offenders with drug related 
problems. District Courts may refer cases to the Drugs Treatment Court. These cases are in 
the first instance assessed for participation by the Probation Service and subject to suitability/
motivation, their progress will be monitored by the Drugs Treatment Court and monitored/
supported through an interagency model. The focus of this intervention is on addressing the 
substance misuse issues and thereby supporting the offender desist from crime reducing the 
likelihood of further offending. The process is diversionary and can prevent progression to 
conviction for those referred. It was noted that this intervention is cross-cutting, involving an 
alternative to imprisonment and referral to treatment and education interventions.
The Minister for Justice and Equality is examining options as a way forward for the operation 
of the Drug Treatment Court. The matter will be progressed alongside wider justice reforms 
that are also under consideration, such as the proposal to establish a Community Court. 
An independent review of the Drug Treatment Court could inform the Minister’s deliberations, 
and the initiative should continue to be supported in the meantime.
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Community Justice Intervention
It should also be noted that a working group within the Justice Sector has been examining 
proposals for the development of a ‘Community Justice Intervention’ initiative aimed at tackling 
low level adult offenders (i.e. those committing relatively minor offences in specific offence 
categories) and effectively addressing their offending behaviour. This would be a diversion 
from the courts system and would have the potential to respond more effectively to one-off 
and repeat, low level offending with the emphasis on speedy processing aimed at reducing the 
risk of re-offending and also to provide quick referral to the necessary services for those that 
need them. This work is at the very early stages and is on-going.
Alternative sanctions for Drug Possession
Many people who use drugs problematically, come into contact with the criminal justice system 
and acquire criminal convictions, either directly or indirectly related to their drug use. Criminal 
convictions can represent a serious impediment for people seeking to move on from drug 
misuse and involvement in crime, particularly in the areas of access to employment, housing 
and travel.
It is worth noting that “UNGASS 2016” encouraged the development of “alternative or additional 
measures with regard to conviction or punishment in cases of an appropriate nature, in 
accordance with the three international drug control conventions” 50.
In June 2015, a joint parliamentary committee on Justice, Defence and Equality visited Portugal 
and discussed the approach to drug addiction adopted there since 2001. It was reported that 
the approach in Portugal has had a very positive result for the communities concerned and is 
therapy-based rather than punitive. Under this system, people found in possession of drugs are 
brought in front of a commission made up of a social worker, a psychiatrist and a lawyer.
Following the visit and subsequent public hearings, the Committee concluded that a health-led 
approach may be more effective and more appropriate for those found in possession of a small 
amount of illegal drugs for personal use, rather than a criminal sanction.
The Committee’s report recommended that the possession of a small amount of illegal drugs 
for personal use, could be dealt with by way of a civil or administrative response rather than via 
the criminal justice route. It also highlighted the need for research to ensure that the adoption 
of any alternative approach would be appropriate in the Irish context.
There is a need to explore the approaches taken in other jurisdictions to the possession of small 
quantities of drugs for personal use in light of the recommendations in the report. This should 
include a review of the current legislative regime in Ireland that applies to simple possession 
offences and the rationale underpinning this approach.
No. Strategic Action Delivered by: Lead 
Agency
Partners
3.1.31 Keep legislation 
up-to-date to deal 
with emerging 
trends in the drugs 
situation.
Keep legislation under review, against 
the background of national, EU and 
broader international experiences and 
best practice, to deal with emerging 
trends, including:
a) new synthetic substances;
b) new or changed uses of 
psychoactive substances; and
c) the evolving situation with regard 
to drug precursors and the surface 
web and dark net drug markets.
DOH, 
DJE
AGS, 
Revenue’s 
Customs 
Service, 
HPRA
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No. Strategic Action Delivered by: Lead 
Agency
Partners
3.1.32 Reduce rates of 
driving under the 
influence of drugs.
Implementing the measures relating 
to the testing of drivers for drugs and 
alcohol contained in the Road Traffic 
Act 2016.
DTTAS
3.1.33 Reduce drug 
offending 
behaviour 
and promote 
rehabilitation.
Implementing the recommendations of 
the Final Report of the Working Group 
on a Strategic Review of Penal Policy 
of July 2014 relating to drug-offending 
behaviours.
DJE
3.1.34 Map the future 
direction and 
objectives of the 
Drug Treatment 
Court.
a) Carrying out an independent 
evaluation of the Drug Treatment 
Court; and
b) Continuing to support the 
operation of the Drug Treatment 
Court, having regard to the 
recommendations made in the 
2013 review 53, pending the 
outcome of the evaluation.
DJE
3.1.35 Consider the 
approaches 
taken in other 
jurisdictions to 
the possession of 
small quantities 
of drugs for 
personal use with 
a view to making 
recommendations 
on policy options 
to the relevant 
Minister within 12 
months.
Establishing a Working Group to 
consider the approaches taken in 
other jurisdictions to the possession of 
small quantities of drugs for personal 
use in light of the Report of the Joint 
Committee on Justice, Defence and 
Equality on a Harm Reducing and 
Rehabilitative approach to possession 
of small amounts of illegal drugs to 
examine:
a) the current legislative regime 
that applies to simple possession 
offences in this jurisdiction and 
the rationale underpinning this 
approach, and any evidence of its 
effectiveness;
b) the approaches and experiences in 
other jurisdictions to dealing with 
simple possession offences;
c) the advantages and disadvantages, 
as well as the potential impact 
and outcomes of any alternative 
approaches to the current system 
for the individual, the family and 
society, as well as for the criminal 
justice system and the health 
system;
d) the identification of the scope of 
any legislative changes necessary 
to introduce alternative options 
to criminal sanctions for those 
offences;
e) a cost benefit analysis of 
alternative approaches to criminal 
sanctions for simple possession 
offences; and
f) make recommendations to the 
relevant Minister within twelve 
months.
DOH, 
DJE
(Joint)
AGS, Relevant
Departments 
and agencies
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Objective 3.2: Implement effective law enforcement 
and supply reduction strategies and actions to prevent, 
disrupt or otherwise reduce the availability of illicit drugs
Law enforcement is increasingly faced by a more joined up and globalised drug market. 
Drug trafficking groups increasingly exploit the opportunities that this presents, which can 
include the growth in container traffic and parcel delivery services. Organised crime groups 
increasingly establish operational links between countries, or to operate on a transnational basis. 
Demographic changes in Europe also mean that crime organisations can exploit the existence 
of new migrant communities resulting in the need for law enforcement to identify and target 
new organisations becoming active on their territories.
The increased prevalence of cannabis cultivation facilities has led to a shift in the market, with 
domestically produced high potency herbal products becoming more available and displacing 
imported resin. The growth of the cannabis market in Ireland is associated with increased levels 
of criminality, including drug-related intimidation and violence.
The evolution and spread of NPS continues to be a persistent threat, with the injecting of 
synthetic high potency opioids resulting in harmful consequences for vulnerable users, such 
as the risk of contracting blood-borne viruses.
Significant law enforcement efforts have been invested in intercepting drugs destined for 
the Irish market. International operations spearheaded by law enforcement agencies have 
resulted in significant seizures and the disruption of organised crime networks involved in 
the importation, distribution and sale of illegal drugs in this country.
Ireland participates in international drug fora at EU, Council of Europe and UN level, as 
part of the international effort to counter the world drug problem. An Garda Síochána, 
Revenue’s Customs Service and the Naval Service actively work with partners at EU and other 
international levels to intercept drugs, and precursors for diversion to the manufacture of drugs, 
being trafficked to Ireland. National and international cooperation between law enforcement 
agencies and other bodies, including those involved in identifying and confisgating the 
proceeds of crime, will continue to be strengthened through the international mechanisms 
for cross border cooperation.
The expansion of online markets for drugs, mentioned above, represents a new and potentially 
growing challenge, as do changes in synthetic drug and cannabis production. The internet 
facilitates movement of products, money and information across global borders. Medicines 
and other substances, including controlled drugs, can be sourced through the dark net and the 
surface net. When a website selling psychoactive substances is taken down, it is replaced by 
other websites, almost immediately. Capacity building measures will be necessary to provide 
the technical support and know-how to enable law enforcement agencies to effectively monitor 
online drug markets and prevent their use as a means of trafficking illegal drugs and other 
substances into Ireland.
In line with the Garda Síochána Strategy Statement 2016-2018 54, and supported by the 
Garda Síochána Modernisation and Renewal Programme for the period 2016-2021 55, An Garda 
Síochána will continue to confront drug related crime utilising intelligence-led operations and 
multi-disciplinary approaches to targeting organised crime groups and individuals involved in 
crime.
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An Garda Síochána has recently strengthened its response to organised criminality including 
drug crime through the establishment in 2016 of a consolidated Garda National Drugs and 
Organised Crime Bureau (GNDOCB). The GNDOCB works closely with other specialist National 
Garda Units including the newly established Special Crime Task Force and with local Garda 
Divisions in targeting persons involved in drug related criminality.
Multi-disciplinary approaches will continue to be utilised to ensure the activities of individuals 
and groups involved in criminal enterprise are effectively targeted, including the use of the 
proceeds of crime legislation, money-laundering legislation and the powers of the Criminal 
Assets Bureau (CAB). The GNDOCB works closely with the CAB in a collaborative approach 
to ‘follow the money’ and target proceeds of crime.
Recognising the importance of this approach An Garda Síochána is committed to 
strengthening the role played by Divisional Asset Profilers in working with the CAB so as to 
target the proceeds of crime at local level, including proceeds of crime generated by low and 
mid level criminals.
Community Impact Statements (CIS) are used in the criminal justice system in the UK to 
provide relevant and useful additional information about the impact crime or a particular 
incident is having on a particular community. A CIS is a statement compiled with the authority 
of a Police Force in active partnership with the community and other stakeholders, describing 
the impact of anti-social-behaviour on a specific neighbourhood or identifiable group of people. 
The intention is to enable better informed decisions that are made with the knowledge of the 
local context and can be used throughout the justice system.
In order for CIS to be used in the Criminal Justice system in Ireland, legislation would be 
required. The Group noted that the Garda Inspectorate Report on Crime Investigation 
recommends that An Garda Síochána, in consultation with the Director of Public Prosecutions, 
should consider the use of CIS in the Criminal Justice system in Ireland. In addition the Group 
noted that the Garda Commissioner has set up a group to examine the recommendations of 
the Garda Inspectorate Report 2014 56, which refer to the use of Community Impact Statements 
in Ireland.
No. Strategic Action Delivered by: Lead 
Agency
Partners
3.2.36 Support the role of law 
enforcement authorities 
in monitoring drug 
markets, in particular 
new drug markets, 
surface web and 
darknet drug markets.
Investing in capacity building 
measures to support the role 
of law enforcement authorities 
in monitoring drug markets, in 
particular new drug markets, surface 
web and darknet drug markets.
AGS, 
Revenue 
Custom’s 
Service
DOH, 
DJE, 
HPRA
3.2.37 Consider the case for 
the use of Community 
Impact Statements 
within the Criminal 
Justice System in 
Ireland.
Subject to the completion of the 
Garda examination of Community 
Impact Statements, bringing 
forward recommendations on their 
implementation.
AGS
60 Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
Objective 3.3: Develop effective monitoring and 
responses to evolving trends, public health threats 
and the emergence of new drug markets
Ireland’s Early Warning and Emerging Trends committee is chaired by the Department of Health. 
This committee is currently the forum through which information from national and EU sources 
on new psychoactive substances (NPS) of concern is received and shared, in the context of 
Council Decision 2005/387/JHA on information exchange, risk assessment and control of new 
psychoactive substances.
One of the major challenges facing Customs Administrations and Law Enforcement agencies 
in general is the ability to rapidly and easily identify NPS when encountered. This task is made 
more difficult by the wide range and complexity of products available on the market, together 
with the tendency for manufacturing chemists to make frequent, and often minor, changes to 
composition which takes them outside the analytical capability of available frontline technology. 
A lack of international research on the composition and effects of NPS can hamper efforts to 
place controls on such substances and provide expert testimony in court cases involving the 
sale or supply of NPS.
Reporting and analysis
Monitoring work also includes the reporting and analysis of data relating to the distribution 
and sale of controlled substances and the scientific analysis of drugs seized. The latter 
is particularly important with regard to NPS. The range and complexity of NPS and the 
unpredictable, sometimes catastrophic, nature of their effect on the user requires a closely 
integrated early warning system that can respond to incidences and report accurately and 
quickly. This system facilitates communication between a range of information sources in 
health and law enforcement agencies, laboratories and government departments.
Monitoring NPS presents challenges to laboratories and there is a need to develop analytical 
capacity, data collection and public warning mechanisms. It is essential to avoid inaccurate 
communication around high profile drug ingestions and laboratories need to develop the 
analytical protocols for accurate identifications of substances and distinguish between 
analogues with only tiny variations.
Government recognises the importance of developing the analytical capacity of the laboratories 
involved in identifying substances, and has made a commitment to provide funding in the 
capital expenditure programme for the construction of a purpose built new laboratory for 
Forensic Science Ireland (FSI), with €6m prioritised to enable the commencement of building 
work two years earlier than originally scheduled.
Presumptive Drug Testing
Presumptive Drug Testing (PDT) was introduced in February 2011 It is limited to Section 3 
(personal possession) cases involving Cannabis, Cannabis Resin or Cocaine where the suspect 
admits that the substance is one of these drugs and that it is for his or her immediate personal 
use. PDT was introduced to reduce the number of Section 3 cases being submitted to FSI 
for analysis so as to permit it to focus its analytical resources on Section 15 (dealing) cases. 
However, the system has had only limited success. The principal reason for this is legal issues, 
which arise in the District Courts. The matter continues to be examined by the Working Group 
to Identify and Report on Efficiencies in the Criminal Justice System/Circuit and District Court.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
3.3.38 Strengthen the 
response to 
the illegal drug 
market, including 
the changing 
nature of new 
psychoactive 
substances.
a) Continuing to develop systems 
to monitor changing drug 
trends in line with the EU Early 
Warning System;
b) Completing the development 
of the HSE public alert system 
for adverse events due to 
drugs and commencing 
implementation;
c) Supporting government 
funded laboratories, tasked 
with analysis of drugs of abuse, 
to engage in novel analytical 
development work, in relation 
to psychoactive drugs but 
especially new psychoactive 
substances (licit or illicit), while 
continuing to fulfil their core 
functions;
d) Providing funding in the capital 
expenditure programme for the 
construction of a purpose built 
new laboratory for Forensic 
Science Ireland with €6m 
prioritised to commence the 
project immediately; and
e) Strengthen the legal robustness 
of Presumptive Drug Testing 
(PDT) to contribute to the 
timely prosecution of Section 
(3) drug-related offences.
DOH 
 
 
HSE 
 
 
 
DPER, 
DTTAS 
 
 
 
 
 
 
 
DJE
HSE, HRB, FSI, 
State Lab, MBRS
AGS 
DOH, HSE, DJE
Performance indicators related to Goal 3
l Participation of relevant sectors and experts in the Early Warning and Emerging Trends 
Sub-Committee (DoH).
l Timely and coherent response to adverse incidents (HSE figures).
l The volume of drugs seized that are considered to be intended for the Irish market 
(AGS/Revenue’s Customs data).
l Number of prosecutions for importation, manufacture and distribution of illicit drugs 
(Recorded Crime Offences).
l The number of supply detection cases (Recorded Crime Offences).
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CHAPTER 6 – Goal 4: Support 
participation of individuals, families 
and communities
Objective 4.1: Strengthen the resilience of communities 
and build their capacity to respond
Promoting community participation and involvement
Building the resilience of communities to respond to the drug problem is a key feature of 
Ireland’s drugs policy. It recognises the importance of enabling communities to participate 
in shaping the decisions that affect them, through providing opportunities for meaningful 
participation and engagement in policy development and decision-making.
There are a great variety of community and voluntary organisations in Ireland whose knowledge 
of local concerns and commitment to their own area helps to build a community’s capacity to 
respond to these concerns with flexibility and sensitivity. Such organisations play a valuable 
role in promoting positive social change, in partnership with the local communities and 
communities of interest they serve.
Supporting social connectedness and involvement in community life are key to empowering 
people at the individual level and building strong communities for health and wellbeing. 
This approach is a core theme of the Healthy Ireland Framework, which states that building 
awareness of and action on the social determinants of health will assist communities to 
organise and mobilise their response to the challenges that affect health and wellbeing 
within their own communities.
Community organisations working in disadvantaged areas give a voice to the most marginalised 
and build the capacity of individuals, families and communities to organise and participate 
in decision-making around the issues that affect them. Prevalence of poor health and social 
problems is markedly higher in those communities with the greatest levels of deprivation. 
These are the communities most susceptible to consequences of problem drug use.
Understanding the underlying socio-economic and cultural factors which contribute to the 
drug problem has resulted in the development of an integrated whole-of-government response 
based on a partnership approach between the statutory, community and voluntary sectors. As 
key stakeholders in addressing the drug problem, it is crucial that communities are supported to 
effectively participate in partnership structures at local, regional and national level. The need for 
improved coordination in service provision and to utilise the knowledge and experience of local 
communities in designing and delivering those services led to the establishment of Local Drugs 
Task Forces (LDTFs) in areas with the highest prevalence of problem drug use. Regional Drugs 
Task Forces (RDTFs) were later established to complement this effort in the parts of the country 
not covered by the LDTFs. They have been key to the development of practical services such 
as treatment and rehabilitation facilities through supporting and funding local initiatives. Task 
Forces have also played a key role in harnessing the efforts of community groups, families and 
local residents and have built partnerships with statutory services and local representatives.
Local Community Development Committees (LCDCs) are responsible for directing SICAP 
funding to those areas that are most socially disadvantaged, in accordance with the needs 
and priorities identified in the Local Economic and Community Plans and the County 
Development Plans informed by the key demographics for each area. There is potential for 
LCDCs to improve their links with Task Forces over time. SICAP’s vision is to improve the 
life chances and opportunities of those who are marginalised in society, living in poverty 
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or in unemployment, through community development approaches, targeted supports and 
interagency collaboration. SICAP Programme Implementers actively encourage the engagement 
and participation of disadvantaged individuals and marginalised communities in local 
development and supports them to enhance their participation in local, regional and national 
decision-making structures.
Participation in key decision-making structures, whether local councils or structures within 
Public Participation Networks (PPNs), allows SICAP target groups to affect change in their 
locality, increase their sense of empowerment and ultimately to improve their wellbeing. Whilst 
operating within a national programme framework, the programme affords sufficient local 
flexibility to Programme Implementers to be able to respond to local priorities as individual 
communities throughout the country have particular needs and circumstances may differ 
considerably between them.
Initially established in response to a largely heroin problem, Task Forces have had to adapt 
to an evolving drug situation. During the period of the current strategy, cannabis has become 
the main problem drug for young people presenting to treatment services for the first time. 
Polydrug use, misuse of prescription medication and new psychoactive substances present 
new challenges to the overall health and security of communities. Alcohol misuse, particularly 
in combination with other forms of problem drug use, presents particular difficulties in 
marginalised communities. In recognition of the scale of the difficulties associated with alcohol, 
and of the potential of community mobilisation in responding to it, the task forces were 
renamed Drug and Alcohol Task Forces (DATFs) in 2012.
Targeting communities affected by the drug problem
The consequences of substance misuse affect different communities disproportionately. The 
analysis provided in the Performance Measurement Framework for Drug and Alcohol Task 
Forces confirms that there is a close connection between the level of problem substance use 
and levels of deprivation and other adverse social conditions in urban areas. The relevance of 
the Framework to improved targeting of resources on the basis of social need and reducing 
the negative impact of socio-economic disparities is outlined in more detail in Chapter 8 of 
this report.
There are a number of data sources available that can be used both to identify risk factors 
in a particular area and assess the impact of efforts to strengthen protective factors. Using 
information on the prevalence of opiate use and other high risk drug use we can identify the 
areas most affected. Drug-related deaths information from communities most affected by the 
fatal consequences of substance misuse help to establish the link between social and economic 
determinants and drug-related mortality.
It can be difficult to assess the real impact of drug markets and other illegal activity on a 
community, even when the consequences of these activities are very apparent to the people 
living there. One approach might be to identify indicators, derived from health, law enforcement 
and other monitoring systems, that can be used to measure the effects of high level problem 
drug use, and the crime and antisocial behaviour associated with it, within a defined area. 
Analysis using these indicators could provide valuable information to a community preparing 
and evaluating a response to these problems.
Criminal activity and an active illicit drug market can create an intimidating and frightening 
environment in an affected community. The concentration of illicit drug markets in particular 
areas means that already marginalised communities must also deal with social and public 
disorder and property crime associated with the sale and distribution of drugs. The use of 
violence or the threat of violence to enforce debts further impacts on these communities by 
creating an atmosphere of fear and undermining the health and wellbeing of families affected 
and the wider community.
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The National Drug-Related Intimidation Reporting programme, developed by the National 
Family Support Network and An Garda Síochána, provides a framework to allow reporting of 
an incident of intimidation to a nominated inspector. Further development of the community 
approach to this problem will need to be informed by evaluations of these and other initiatives 
being undertaken in a number of taskforce areas. A review by the HRB of the international 
literature on gang prevention, desistence from gangs and criminal and legal interventions to 
counter gang activity, will be useful in informing the development of a collaborative response 
to intimidation involving law enforcement agencies, social services, schools and community 
organisations 57.
The task of building safer, more resilient communities will be helped by the type of cooperation 
and mutual support between An Garda Síochána and community representatives that has 
been established during the period of the first two drug strategies. An Garda Síochána 
representatives sit on task forces, and mechanisms such as Local Policing Fora help to build 
important intra-sectoral relationships within communities.
Joint Policing Committees, facilitate the important work of consultation and cooperation 
between An Garda Síochána, local authority officials and community representatives on which 
effective community policing depends. In line with the Garda Síochána Strategy Statement 
2016-2018 54 and the 2017 Crime Prevention and Reduction Strategy 58, and supported by the 
Garda Síochána Modernisation and Renewal Programme 2016-2021 55, An Garda Síochána is 
continuing to promote and embed a new community policing ethos across An Garda Síochána 
to enhance trust and confidence and to ensure a visible, accessible and responsive service and 
implement a suite of customised crime prevention approaches to protect communities from 
crime.
A range of initiatives designed to deliver on strategic commitments will include strengthened 
community engagement through the Community Policing Teams and Community Safety 
Fora so as to identify neighbourhood issues impacting on the quality of life and the measures 
needed to address them. As part of the crime prevention through partnership response 
An Garda Síochána is also committed to designing and implementing a revised approach to 
offender management including youth offenders and recidivist offenders in the community 
through inter-agency partnerships.
Recognising the harm caused by drug-related debt intimidation, An Garda Síochána will 
carry out an evaluation of the Drug-Related Intimidation Reporting Programme to strengthen 
its effectiveness and to identify further opportunities to build on that work through Community 
Safety Fora and the creation of linkages with community policing and the asset profiling 
programme. The National Family Support Network, who have worked with An Garda Síochána 
to build support for this programme, will also carry out their own evaluation from the 
perspective of their network. These reviews will further inform development of the reporting 
programme by An Garda Síochána and The National Family Support Network.
The depth of experience and knowledge built up by the community sector in responding 
to this situation will be an immensely valuable resource to this strategy.
65Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
No. Strategic Action Delivered by: Lead 
Agency
Partners
4.1.39 Support and 
promote community 
participation in all 
local, regional and 
national structures.
Supporting and promoting 
community participation in all local, 
regional and national structures.
DOH Community 
Sector, LAs, 
DHPLG, 
DATFs
4.1.40 Measure the 
impact of drug-
related crime 
and wider public 
nuisance issues on 
communities.
Developing and piloting a Community 
Impact Assessment Tool in order to 
measure the impact of drug-related 
crime and wider public nuisance 
issues on communities.
C&V 
sectors
4.1.41 Enhance the 
relationship 
between an Garda 
Síochána and 
local communities 
in relation to the 
impact of the drugs 
trade.
Building on the achievements of 
Local Policing Fora in providing an 
effective mechanism for building and 
maintaining relationships between 
an Garda Síochána and the local 
communities, in particular in relation 
to the impact of the drugs trade.
DJE, 
DHPLG, 
AGS
4.1.42 Strengthen the 
effectiveness of 
the Drug-Related 
Intimidation 
Reporting 
Programme.
An Garda Síochána and the National 
Family Support Network will each 
carry out its own evaluation of the 
Drug-Related Intimidation Reporting 
Programme to strengthen its 
effectiveness and, if appropriate, 
develop measures to raise public 
awareness of the programme.
AGS, 
NFSN
Objective 4.2: Enable participation of both users 
of services and their families
As important stakeholders, service users and their families have a key role to play in 
contributing to the planning, design and delivery of effective services. Service users, because 
of their direct experiences of services, have unique insights which are a valuable resource to 
those involved in developing services and interventions. Facilitating their involvement in the 
development and design of services is therefore a core objective of drugs policy.
The term ‘service user’ includes people who use health and social care services and their 
families. It also includes people who are potential users of health services and social care 
interventions, including people who use drugs, who may not yet have availed of treatment.
All HSE and HSE funded addiction services in primary care are expected to work within 
the National Standards for Safer Better Health Care 59. These standards reflect many of the 
elements that have been outlined within this Reducing Harm, Supporting Recovery, such as 
the importance of person-centred care and ensuring that service users’ needs and preferences 
inform the planning, design and delivery of services.
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Service user involvement is about facilitating people to become meaningfully involved in 
defining the issues of concern to them, in making decisions about factors that affect their lives, 
in formulating policies and in planning, developing and delivering services, and in taking action 
to achieve change.
Involvement in their own care or treatment plan
People who use services should have the opportunity to make informed decisions about their 
care and treatment, in partnership with their healthcare professional, including setting their own 
treatment and recovery goals. Good communication and the provision of adequate information 
is key to ensuring that people who use services are enabled to make informed decisions 
about their care, including informed decision-making to give or refuse consent to treatment. 
A key worker should be assigned to work closely with the service user to facilitate his or her 
participation in the care planning process, including the setting of treatment goals.
Patient safety and quality is one of the four core elements of the recently adopted HSE 
Accountability Framework. In addition, health professionals are guided by their codes of ethical 
and professional conduct. Assurance of patient safety requires active leadership, governance 
and clinical commitment to quality. Each substance misuse service should have a defined 
patient safety and quality operating framework to address service user advocacy, complaints 
and learning procedures, incident management and response, and substance misuse quality 
elements such as standards, guidelines, audit and performance indicators in order to foster 
a patient safety culture.
Peer-led services can support person-centred care, by providing social support to the individual 
during and after treatment.
Involvement in improving service delivery
In addition to being involved in their own care, service users should be enabled to participate in 
the development of local services. Services should provide service users with the opportunity 
to provide constructive feedback on both positive and negative experiences of attending the 
service. This may include suggestions about how to improve the service they are attending, 
participate in activities to facilitate feedback and discussion. This can be achieved through a 
variety of methods such as questionnaires, suggestion boxes, and regular meetings and can 
be on a one-to-one and/or group basis. The HSE plans to undertake a service user experience 
survey and to subsequently address the findings.
Involvement in decision-making structures
Service users should also be facilitated to participate in the local, regional and national decision-
making structures of the strategy. Service users also have an important role to play in ensuring 
that the design and delivery of drug and alcohol treatment services meets the needs of those 
with drug or alcohol problems. Organisations, networks and advocates provide a platform for 
service users to voice their concerns and ensure that there is meaningful engagement at all 
levels. The consultation process for this strategy involved substantial engagement with service 
users across the country and networks of people who use drugs and services and their families 
were involved in the Steering Committee tasked with developing proposals for the new strategy.
Support for independent representation for those who use drugs, as well as those who are 
using services, is recognised good practice for enabling advocacy and improving outcomes.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
4.2.43 Build capacity within drug 
and alcohol services to 
develop a patient safety 
approach in line with the 
HIQA National Standards 
for Safer Better Healthcare.
Requiring the delivery 
of services within a 
Quality Assurance 
Framework, which will
a) standardise 
services;
b) include basic 
tools in relation to 
safety, complaints, 
competencies and 
procedures around 
prescribing; and
c) reflect a human 
rights based and 
person centred 
approach.
DOH HSE
4.2.44 Promote the participation 
of service users and their 
families, including those in 
recovery, in local, regional 
and national decision-
making structures and 
networks in order to 
facilitate their involvement 
in the design, planning and 
development of services 
and policies.
Actively supporting 
frontline services 
through capacity 
building measures using 
evidence based models 
of participation in line 
with best practice.
DOH Relevant 
Departments 
and Agencies, 
C&V sectors, 
DATFs, Networks 
of people who 
use drugs and 
alcohol, Networks 
of people who 
use services and/
Family Support 
Networks
Performance Indicators related to Goal 4
l Uptake of treatment in communities most affected by substance misuse (NDTRS).
l Changes in problem substance use in communities affected by deprivation (NDTRS).
l The number of deaths associated with drug use in marginalised communities (NDRDI).
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CHAPTER 7 – Goal 5: Develop sound 
and comprehensive evidence-informed 
policies and actions
Objective 5.1. Support high quality monitoring, evaluation 
and research to ensure evidence-informed policies and 
practice
Monitoring
Ireland has good information on the substance misuse situation at a national level. Routine 
monitoring provides the information on the nature, extent and consequences of substance 
misuse needed to formulate evidence-informed policy, plan services and measure the 
effectiveness of the responses to this problem. In fulfilment of both European and national 
requirements Ireland’s monitoring system collects and analyses data on drug use in the 
general and school-going population, treatment demand, high-risk drug use and on 
consequences, such as infectious diseases, deaths and overdose.
Monitoring also provides information on harm reduction measures, and on prevention, 
rehabilitation and other demand reduction interventions. Data is gathered through special 
health surveillance systems, such as the National Drugs Treatment Reporting System (NDTRS), 
regular population surveys or studies, published evaluations and analyses. The HSE’s data 
collection systems provide information on infectious diseases, needle exchange and nonfatal 
overdoses.
It is important that monitoring systems are aware of and in a position to exploit new sources 
of data. Longitudinal studies, such as TILDA – The Irish Longitudinal Study on Ageing or 
Growing up in Ireland, present opportunities to complement information from routine 
monitoring with insights into substance use behaviour of particular population cohorts. The 
analysis of trends over the past 10 years carried out to inform this strategy points out that most 
of the information on vulnerable groups was obtained from single studies 11. In order to observe 
trends we will need to explore ways of monitoring drug use and treatment uptake among the 
populations at particular risk.
Evaluation
The strategy will largely be implemented through interventions delivered by statutory, 
community and voluntary services. As evidence is one of the values underpinning the strategy 
it will be expected that these interventions will be based on findings from the most recent 
scientific research and that their implementation will be carefully studied. The effectiveness 
of interventions will be established by measuring outcomes through a system of evaluation 
built into programme plans. This is particularly important when the available evidence does 
not clearly point to a particular course of action and innovative approaches are being followed. 
Evaluation also includes reporting on the extent to which the implementation of an intervention 
adheres to protocols and guidelines associated with the intervention.
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Evidence-informed decision-making can be encouraged by working with services to improve 
their evaluation processes and adopt an outcomes-focussed approach to implementing 
interventions. DATFs, working with the HRB National Drugs Library, have identified a number of 
outcomes that are relevant to the progress of service users in recovery 60. These outcomes are 
organised by particular facets relevant to recovery such as personal circumstance and needs, 
relationships and employment and skills. The framework also identifies validated instruments 
that the taskforces can use to evaluate these outcomes. This project builds on the HRB’s 
research dissemination activities that include specially commissioned reviews, a research 
bulletin, an online library and web-based evidence resources.
Research
Research illuminates topics on which there is limited knowledge and tests the usefulness or 
appropriateness of new approaches to delivering services and coordinating responses. This 
work may involve primary research, secondary analysis of existing datasets, or synthesis 
of existing research to ensure the highest quality evidence is available to practitioners and 
policymakers. The HRB’s review of reviews 12 is an example of this synthesis and the strategy 
will continue to build on this valuable resource. In order to derive maximum benefit careful 
consideration should be given to implementing the findings of research and ensuring they 
are central to the decision-making process in service delivery. All research projects, including 
primary research and evidence syntheses should include a programme of dissemination and 
knowledge-to-action activities that engage the stakeholders who will be implementing the 
research findings.
While Ireland has good information at the national level, information on service needs and 
on the implementation of interventions at the local level is less comprehensive. As the Rapid 
Expert Review 10 noted, there are well managed and evaluated programmes throughout the 
country. These could provide examples of good practice if there was a means of thoroughly 
cataloguing them and making this knowledge available in a systematic way. This resource could 
be very valuable in guiding decision-making and supporting innovative services who want to 
use evidence in the selection, implementation and measurement of interventions. Findings 
from individual programme evaluations can be aggregated and further analysed when there is 
a shared approach to measuring interventions that have outcomes in common. In this way new 
evidence can be created leading to refinement and further service improvement. So, monitoring, 
evaluation, research and knowledge transfer are interdependent activities supporting good 
practice, consistency and more effective services.
Adapting swiftly to rapidly changing conditions using reliable information will be an essential 
attribute in the strategic response to substance misuse in the coming years. Developing this 
capacity will require reliable, timely and comparable information. A robust, flexible and inclusive 
system of monitoring, evaluation, knowledge transfer, and research can provide this resource.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
5.1.45 Strengthen Ireland’s 
drug monitoring 
system.
a) Continuing to monitor the drug 
situation and responses for national 
and international purposes using 
EMCDDA protocols and existing 
data collection systems, while 
ensuring that Ireland can respond 
to new data monitoring requests 
arising from the National Committee 
and the European Union during the 
term of the Strategy;
b) Separating the organisation and 
budgeting of routine monitoring 
from research projects;
c) Requesting all remaining hospital 
emergency departments include 
the monitoring of attendances as 
a result of alcohol and drugs use in 
their electronic patient system; and
d) Developing a suitably integrated 
IT system which allows for the 
effective sharing and collection 
of appropriate outcome data.
HRB 
 
 
 
 
 
 
 
 
DOH 
 
DOH 
 
 
 
HSE
DOH, 
HSE, 
HRB
5.1.46 Support evidence-
informed practice 
and service provision.
a) Ensuring that public funding is 
targeted at underlying need and 
supports the use of evidence-
informed interventions and the 
evaluation of pilot initiatives;
b) Designating the Health Research 
Board as a central information hub 
on evidence on the drugs situation 
and responses to it;
c) Ensuring that mechanisms are in 
place to communicate this evidence 
in a timely manner to those working 
in relevant healthcare settings, 
including in acute and emergency 
care; and
d) Developing collaborative 
relationships with third level 
institutions in the area of drugs and 
alcohol so as to further government 
funded research priorities.
DOH DES, 
DSP, 
DCYA, 
HSE, IPS, 
PS, HRB
5.1.47 Strengthen the 
National Drug 
Treatment Reporting 
System (NDTRS).
Requiring all publicly funded drug and 
alcohol services to complete the NDTRS 
for all people who use services.
DOH, 
DJE
HSE, 
IPS, C&V 
sectors
5.1.48 Develop a prioritised 
programme of drug 
and alcohol-related 
research on an 
annual basis.
Harnessing existing data sources in 
the drug and alcohol field in order to 
enhance service delivery and inform 
policy and planning across government 
and the community and voluntary 
sectors, and having done so, identify 
deficits in research in the field to 
enable the development of a prioritised 
programme on an annual basis.
DOH HSE, 
HRB
71Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
No. Strategic Action Delivered by: Lead 
Agency
Partners
5.1.49 Improve knowledge 
of rehabilitation 
outcomes.
Undertaking a study on rehabilitation 
outcomes, which takes into account the 
experience of service users and their 
families, and examines their outcomes 
across multiple domains, building on 
work already undertaken.
DOH, 
HRB
(joint)
HSE, 
UISCE, 
NFSN, 
C&V 
sectors
Performance Indicators related to Goal 5
l General population survey completed and results published (Drugs Prevalence Survey).
l Opiate prevalence study completed and results published (DoH).
l Increase in the number of publicly funded drug and alcohol services completing NDTRS 
forms (NDTRS).
l Annual Prioritised research programme agreed.
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CHAPTER 8 – Strengthening the 
performance of the strategy
Resources should be directed towards those interventions and strategies which are most likely 
to lead to a reduction in problem substance use and a positive improvement in public health, 
safety and wellbeing. The need for a way of measuring the overall effectiveness of the response 
to the drug problem is therefore an important objective of public policy.
The level of progress achieved in delivering on the goals and related objectives and actions 
of the strategy will be determined using performance indicators linked to each objective. 
In addition, the key bodies responsible for delivering the strategic actions will be required 
to report on progress on an annual basis to the Minister with responsibility for the National 
Drugs Strategy. Monitoring of the progress in implementing the strategy will be supported 
by a coordinated system of monitoring, evaluation and research as set out in in Goal 5.
A performance measurement system has been developed by independent external consultants, 
Trutz Haase Social and Economic Consultants, to help Government assess whether the drugs 
strategy is leading to an improvement in problem substance use across the country 61. This 
measurement system goes further than an examination of progress in delivering on the actions 
to support implementation of the strategy and their results, as set out in an annual report. The 
performance measurement system is primarily concerned with the net effects of the strategy 
at the population level, in particular, the effects on the health, wellbeing and quality of life of 
people living in local and regional DATF areas.
Reducing Harm, Supporting Recovery has a number of population-based objectives and 
it is only by measuring the population effects of interventions that these objectives can be 
evaluated. The system takes into account the complex range of factors that can increase the 
risk of problem substance use in an area, such as social problems, deprivation and levels of 
social housing. When results at the local level are aggregated the success of the strategy as 
a whole can be assessed.
The model which is at the core of the measurement framework makes predictions regarding 
the level of problem drug use in a small area based on a number of social indicators describing 
levels of deprivation, urbanity and social class. It then compares the predicted level of problem 
substance use with the actual prevalence of problem substance use, on the basis of routine 
monitoring systems, such as drug treatment data. If significant changes in problem drug or 
alcohol use are found from one year to the next, or differences are observed between DATF 
areas, there is an opportunity to analyse why such differences have emerged.
By identifying reasons for differences in outcomes, important and valuable information can 
be obtained to support the successful implementation of the strategy. It will also facilitate 
performance improvement in areas of the country where the strategy appears to be less 
successful. This can also help DATFs improve their actions and interventions over time.
The performance measurement system incorporates a resource allocation model (RAM) 
to enable funding to be allocated on a more equitable and rational basis, takes account of 
underlying need in DATF areas and targets those communities which face a higher risk of 
substance misuse. The RAM is currently based on the DATF global allocation, but it is intended 
that over time the RAM will take into account the totality of public funding at the disposal 
of the DATF partners. As information systems improve in the coming years, the performance 
measurement system can draw upon more data sources to develop a more precise measure 
of problem substance use.
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The active participation and collective buy-in of all the key stakeholders will be extremely 
important to the success of the system. Bringing forward measures to achieve positive change 
and improve outcomes for individuals, families and communities affected by problem substance 
use will require the commitment of all the key departments, agencies, DATFs and service 
providers. It is therefore intended to develop an implementation plan to operationalise the 
Performance Measurement Framework by 2020, in consultation with relevant stakeholders 
and sectors. The implementation plan will aim to ensure that Task Forces have appropriate 
arrangements in place for the selection and renewal of the Chair and members of the Task 
Force and have proper procedures in place for addressing conflict of interest. It is envisaged 
that these arrangements will be in line with the principles outlined in the Review of Drug Task 
Forces (2011/12) 62.
No. Strategic Action Delivered by: Lead 
Agency
Partners
6.1.50 Develop an 
implementation plan 
to operationalise 
a Performance 
Measurement System 
by 2020 which will 
support Reducing 
Harm, Supporting 
Recovery, improve 
accountability 
across the statutory, 
community and 
voluntary sectors 
and strengthen the 
Drug and Alcohol 
Task Force model, 
in consultation with 
relevant stakeholders 
and sectors.
a) Phasing in the introduction of a 
resource allocation model (RAM) 
to achieve a more equitable 
distribution of resources across 
Task Force areas. This will involve 
monitoring and assessing the 
evidence from the operation of the 
RAM on an annual basis;
b) Identifying where significant 
changes in problem drug or alcohol 
use are found from one year to the 
next, or differences are observed 
between areas, and analysing why 
such differences have emerged with 
a view to successfully implementing 
the strategy and assisting 
DATFs improve their actions and 
interventions over time;
c) Improving the alignment of Task 
Force boundaries;
d) Ensuring that Task Forces have 
appropriate arrangements in place 
for the selection and renewal of 
the Chair and members of the Task 
Force and have proper procedures 
in place for addressing conflict of 
interest;
e) Building the capacity of DATFs 
to participate in the Performance 
Measurement System; and
f) Coordinating a cross-Departmental 
approach at national and local level 
to allow for the gathering of the 
appropriate information and data 
streams to feed into the ongoing 
organic further development of 
the Performance Measurement 
Framework.
DOH HSE
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The coordination of the implementation of the 2009-2016 National Drugs Strategy was initially 
led by a Minister/Office of the Minister for Drugs at the Department of Community, Rural and 
Gaeltacht Affairs. The organisational structure of the current strategy is set out in the figure 
below.
Figure 10: Organisational structure of the National Drugs Strategy 2009–2016
Government
Cabinet Committee on Social Inclusion, Children and Integration
Minister/Office of the 
Minister for Drugs
Drugs Advisory Group – replaced by National 
Coordinating Committee on DATFs
Drug and Alcohol Task Forces
Oversight Forum 
on Drugs
Statutory Agencies
National Advisory 
Committee on Drugs
The main role of the Office of the Minister for Drugs was to ensure national coordination of 
the Strategy, support policy development, support the work of the Task Forces, support the 
National Advisory Committee on Drugs (NACD), and support the community and voluntary 
sector. Following a change of Government in 2011, the national drugs strategy function 
was transferred to the Department of Health and the functions of the Office of the Minister 
for Drugs, including the Drugs Advisory Group, were taken over by the Drugs Policy and 
Programmes Unit within that Department.
A review of Drug Task Forces was undertaken in 2011/12 to assess the impact of Drug Task 
Forces in order to ensure that they would continue to remain relevant, effective and fit for 
purpose. The review also led to the commissioning of research into the development of a 
Performance Measurement Framework for DATFs, which has been outlined above.
The Rapid Expert Review of the Strategy 10 noted that the current structures and 
communication flows have evolved over time and appear rather complex and disjointed. 
Their recommendations focused on the different functions needed to support the strategy 
rather than on the specific bodies that are currently, or might in the future, be tasked with 
these roles, emphasising:
l Leadership to provide drive, direction/prioritisation;
l Coordination at national and local level;
l Mobilisation of resources in terms of finances and personnel, including those 
for whom drugs is not the primary focus of their work;
l Quality assurance and clinical governance involving national bodies working with 
local areas to identify and evaluate innovative approaches and ensure standards are 
maintained;
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l Monitoring and evaluation of progress including appropriate performance indicators 
linked to the specific objectives of the strategy;
l A structure to ensure that research is integrated within the strategy;
l Analysis and advice drawing out the implications of research findings for policy and 
practice to be fed into discussions around direction and prioritisation at national level; 
and
l Needs assessment, coordination and support for local implementation and a review 
of Task Force boundaries in light of current needs.
A more streamlined structure is required to deliver on the key functions identified as important 
by the Rapid Expert Review 10 and to optimise participation in the strategy, in a way which 
avoids duplication and overlap.
National Oversight Committee
Accordingly, it is intended to establish a National Oversight Committee to give leadership and 
direction to support implementation of the strategy. The Committee will meet on a quarterly 
basis and be sponsored by the Minister of State with responsibility for the National Drugs 
Strategy.
Membership
The Committee will have a cross-sector membership from the statutory, community and 
voluntary sector, as well as clinical and academic expertise. Representation from the statutory 
sector will be at the level of Assistant Secretary. It will be a matter for the Minister of State to 
determine the final membership of the Committee, however, the suggested membership is set 
out in the Table below.
Indicative Membership of the National Oversight Committee
Sector Body
Statutory Department of Health – Drugs Policy Unit
Statutory Department of Health – Health and Wellbeing Division
Statutory Health Service Executive
Statutory Health Research Board
Statutory Department of Justice and Equality
Statutory An Garda Síochána
Statutory Irish Prison Service
Statutory Probation Service
Statutory Revenue Customs Service
Statutory Department of Children and Youth Affairs
Statutory TUSLA
Statutory Department of Education and Skills
Statutory Department of Social Protection
Statutory Department of Housing, Planning and Local Government
Statutory Department of Transport, Tourism and Sport
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Sector Body
Community Citywide Drug Crisis Campaign
Community Citywide Drug Crisis Campaign
Community National Family Support Network
Community Union for Improved Services Communication and Education
Voluntary Sector Voluntary Drug Treatment Network
Voluntary Sector Voluntary Drug Treatment Network
Task Force Local Drug and Alcohol Task Force Chairs Network
Task Force Local Drug and Alcohol Task Force Coordinators Network
Task Force Regional Drug and Alcohol Task Force Chairs Network
Task Force Regional Drug and Alcohol Task Force Coordinators Network
Clinical Expert To be appointed by Minister
Clinical Expert To be appointed by Minister
Academic Expert To be appointed by Minister
Terms of reference
The National Oversight Committee will have the following terms of reference:
(a) To give leadership, direction, prioritisation and mobilisation of resources to support 
the implementation of the strategy;
(b) To measure performance in order to strengthen the delivery of drugs initiatives and 
to improve the impact on the drug problem;
(c) To monitor the drugs situation and oversee the implementation of a prioritised 
programme of research to address gaps in knowledge;
(d) To ensure that the lessons drawn from evidence and good practice inform the 
development policy and initiatives to address the drug problem; and
(e) To convene Sub-Committees, as required, to support implementation of the strategy.
Operational Procedures
The National Oversight Committee will develop a prioritised work programme to support 
the implementation of the strategy. The Committee will establish Sub-Committees, as it 
sees fit, to address specific issues and to harness relevant expertise to enable it to deliver 
on its key functions. Such committees will be required to report to the National Committee. 
The number of Sub-Committees and their modus operandi will be a matter for the Chair 
of the National Committee.
Standing Sub-Committee
A Standing Sub-Committee of the National Oversight Committee will be established to drive 
the implementation of Reducing Harm, Supporting Recovery and promote coordination 
between national, local and regional levels. The Sub-Committee will be chaired by a Senior 
Official in the Department of Health. It will play a key role in ensuring that the statutory, 
community and voluntary sectors, Drug and Alcohol Task Forces and other key stakeholders 
are engaged in supporting the implementation of the strategy.
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Membership
There will be a balance of representatives drawn from the statutory, community and voluntary 
sectors. Membership will include, but not be limited to, representation from the networks of the 
Chair and coordinators of the Local and Regional Drug and Alcohol Task Forces, the National 
Family Support Network and UISCE. Statutory membership of the Standing Sub-Committee 
will be at Principal Officer level or equivalent. Representation from the Department of Health 
will include senior officials that are responsible for drug policy and alcohol policy.
Terms of Reference
The Standing Sub-Committee will have the following terms of reference:
(a) To drive implementation of Reducing Harm, Supporting Recovery at national, local 
and regional level;
(b) To develop, implement and monitor responses to drug-related intimidation as 
a matter of priority;
(c) To support and monitor the role of Drug and Alcohol Task Forces in coordinating 
local and regional implementation of the National Drugs Strategy with a view to 
strengthening the Task Force interagency model;
(d) To improve performance, promote good practice and build capacity to respond 
to the drug problem in line with the evidence-base;
(e) To ensure good governance and accountability by all partners involved in the delivery 
of the Strategy; and
(f) To report to the National Oversight Committee on progress in the implementation 
of its work programme.
Operational Procedures
The Standing Sub-Committee will meet on a monthly basis, and agree an annual programme 
of work to support implementation of the strategy. Drug-related intimidation will form part 
of the early work programme agreed by the Standing Sub-Committee, in view of the need to 
commence work on the issue.
Members of the Standing Sub-Committee will develop a liaison relationship with Task Forces 
to support multi-directional coordination and communication between delivery bodies and 
stakeholders at local, regional and national levels.
The standing Sub-Committee will develop capacity building measures to improve 
implementation of the strategy, promote good practice, support the use of evidence and 
strengthen engagement by the community and voluntary sectors in the national structures 
of the strategy.
The Standing Sub-Committee will provide progress reports on the delivery of its work 
programme for the quarterly meetings of the National Committee.
Resources for capacity building
The strategy contains a specific action to support and promote community participation in 
all local, regional and national structures. A dedicated resource will be available to support 
engagement in the national implementation structures, including the Standing Sub-Committee. 
This resource will also be available to build capacity of the partners to implement the strategy 
effectively, through disseminating models of best practice and innovation, evidence-based 
approaches and by facilitating sharing and mutual learning.
The structures proposed by the Department of Health to support implementation of the 
strategy’s objectives are illustrated in Figure 11.
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Figure 11: Structures supporting implementation of Reducing Harm, 
Supporting Recovery
Relevant Cabinet Committee
Minister of State for Health Promotion and the National Drugs Strategy
National Oversight Committee
Leadership / Direction / Prioritisation
Local and Regional Drug and Alcohol Task Force
Needs Assessment and Local Co-Ordination
Standing Sub-Committee
Implementation Support
Other Sub-Committees
As Required
Early Warning and 
Emerging Trends 
Sub-Committee
Health Research Board
Monitoring and Research
Department of Health 
Drugs Policy Unit
Analysis and Advice
Analysis and Advice
The Drugs Policy Unit of the Department of Health will be responsible for the provision of 
objective and informed analysis and advice to the National Committee and its capacity to 
deliver on this role will be strengthened under the new strategy. Its key functions will be:
(a) To analyse the implications of research findings for policy and design of initiatives 
to tackle the drug problem;
(b) To provide advice to the National Committee on the commissioning of new research 
and development of new data sources having regard to current information and 
research deficits and advice and changing patterns of drug use and emerging trends; 
and
(c) To provide a secretariat to the National Committee and the Standing Sub-Committee.
Monitoring, research and evaluation
The HRB will continue in its role as Irish national focal point to the EMCDDA. It will be the 
central information hub for the collection, management and dissemination of data relating to 
the drugs situation, consequences and responses. It will be responsible for reporting to the 
EMCDDA on the five epidemiological indicators, namely:
(a) The prevalence and patterns of drug use among the general population;
(b) Prevalence and patterns of problem drug use;
(c) Demand for drug treatment;
(d) Drug-related deaths; and
(e) Drug-related infectious diseases.
As stated above, the National Oversight Committee will prioritise the research to be 
undertaken to address gaps in knowledge. The HRB will manage the commissioning of 
the research.
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The Early Warning and Emerging Trends Sub-Committee plays a role in the Early Warning 
System. Its original Terms of Reference were:
l To receive, share and monitor on behalf of the Department of Health, information from 
National and EU sources on New Psychoactive Substances of concern in the context of 
the Council Decision of 2005/387/JHA on information exchange, risk assessment and 
control of new psychoactive substances;
l To receive, share and monitor on behalf of the Department of Health, information on 
emerging trends and patterns in drug use particularly poly drug use and associated risks;
l To monitor the work on emerging trends being developed at EU level (EMCDDA 
responsibility), to consider its implementation in Ireland;
l To monitor the reports to the Early Warning System on a quarterly basis about 
emerging trends and New Psychoactive Substances, but more frequently if 
circumstances warrant it;
l To examine new ways of getting sensitive information on changing patterns of drug use 
and trends;
l To consider the implications of changing drug markets and distribution networks which 
can impact on the popularity of certain psychoactive substances; and
l To review the risk assessment reports provided by the EMCDDA and determine their 
relevance to the Irish situation and advise Government accordingly.
The role and terms of reference of the Early Warning and Emerging Trends Sub-Committee, 
within the Early Warning System, will be reviewed under the strategy.
Needs assessment, local coordination and implementation
The current terms of reference of Drug and Alcohol Task Forces require them to coordinate 
the implementation of the strategy in the context of the needs of the local/regional area, 
implement the actions in the strategy where Task Forces have been assigned a role and 
promote the implementation of evidence-based local/regional drug and alcohol strategies 
and to exchange best practice. In 2012, their remit was extended to include alcohol, building 
on their track record in engaging local communities. In the context of promoting an integrated 
public health approach to substance misuse, which is defined as the harmful or hazardous 
use of psychoactive substances including alcohol and illicit drugs, they will furnish an annual 
report to the designated Minister with responsibility for the National Drugs Strategy. The 
general arrangements for reporting will be determined by the standing Sub-Committee 
for implementation support.
The Task Forces are the key bodies to provide needs assessment, local coordination and 
implementation and the performance measurement framework will provide Task Forces with 
the information required to more effectively fulfil these functions. The Minister for Health 
Promotion and the National Drugs Strategy will convene meetings with the DATFs as required.
Boundary issues
Local and Regional DATFs have been effective in promoting cooperation between the statutory, 
community and voluntary sectors. They have also provided a targeted response to drugs 
issues as they affect people on the ground. It has been suggested, in the past, that the large 
number of Local DATFs creates administrative difficulties and unnecessary complications in 
the relationship with other service providers. These agencies are often required to interact 
with multiple Local DATFs within a given catchment area. The RAM within the Performance 
Measurement Framework provides a rational basis for addressing the boundary issues that 
arose for historical reasons following the establishment of Regional DATFs, in and around the 
Dublin areas.
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CHAPTER 9 – Conclusion
This strategy was drawn up by a Steering Committee, established in December 2015, by the 
Minister with special responsibility for the National Drugs Strategy.
The process of developing the strategy involved an intensive process of public consultation, a 
rapid expert review, a review of reviews of interventions to tackle the drug problem, an analysis 
of drug trends in the past decade and a series of engagements with key stakeholders to identify 
gaps in the current response to the drug problem. The independence of the process was 
assured by an independent chair, who guided the Steering Committee in its work.
The core objective of the new strategy is to provide an integrated public health response to 
substance misuse, which recognises that substance misuse includes the harmful or hazardous 
use of psychoactive substances, including illegal drugs, alcohol and prescription medicines. It 
underlines the importance of a health-led person-centred approach to tackling the problem of 
substance misuse. It contains a series of actions which are to be delivered over the next four 
years (2017-2020). These are set out in Chapter 10 of this document. Key partners are identified 
to drive implementation of the actions, while recognising there will be many actions of a cross-
sectoral nature requiring input from a range of stakeholders.
It aims to achieve a whole-of-government response to problem substance misuse by 
highlighting other policy frameworks and strategies which will contribute towards addressing 
the risk factors for substance misuse in our society, and makes suggestions for achieving 
greater synergies with these strategies and policies into the future. A list of the relevant 
strategies and policy frameworks are provided in Appendix 2 of the document. The strategy is 
a dynamic process, that will be monitored through the key national, local and regional stuctures 
charged with ensuring the implementation of the strategy. There will be flexibility to introduce 
new measures after four years to address issues which emerge during that period.
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CHAPTER 10 – Strategic action plan for 
the period 2017-2020
No. Strategic Action Delivered by: Lead 
Agency
Partners
1.1.1 Ensure that the 
commitment to an 
integrated public 
health approach to 
drugs and alcohol 
is delivered as a key 
priority.
a) Developing an initiative to 
ensure that the commitment 
to an integrated public health 
approach to drugs and alcohol 
is delivered as a key priority; 
and
b) Promoting the use of evidence 
based approaches to mobilising 
community action on alcohol.
DOH HSE, DATFs
1.1.2 Improve the delivery 
of substance use 
education across all 
sectors, including 
youth services, 
services for people 
using substances 
and other relevant 
sectors.
a) Organising a yearly national 
forum on evidence-based and 
effective practice on drug and 
alcohol education; and
b) Developing a guidance 
document to ensure substance 
use education is delivered 
in accordance with quality 
standards.
HRB HSE, DOH, 
DES, DCYA
1.2.3 Support the SPHE 
programme.
a) Promoting continued effective 
communications between 
local schools and Drug and 
Alcohol Task Forces given 
the importance placed on the 
continued building of strong 
school community links; and
b) Ensuring that all SPHE teachers, 
guidance counsellors and 
Home School Community 
Liaison co-ordinators can avail 
of continuing professional 
development.
DES, 
DATFs 
(Joint) 
 
 
 
DES
1.2.4 Promote a health 
promotion 
approach to 
addressing 
substance misuse.
In line with the Action Plan for 
Education
a) Commencing and rolling out 
a national programme to 
support the implementation 
of the Wellbeing Guidelines to 
all primary and post-primary 
schools; and
b) Developing Wellbeing 
Guidelines for Centres of 
Education and Training.
DES DOH/HSE
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.2.5 Improve supports 
for young people 
at risk of early 
substance use.
a) Providing a continuum of 
support including a Student 
Support Plan as appropriate, 
for young people who are 
encountering difficulty in 
mainstream education;
b) Providing access to timely 
appropriate interventions 
such as resilience-building 
programmes, and/or 
counselling, educational 
assessments and/or clinical 
psychological assessments, 
as appropriate;
c) Implementing School 
Attendance Strategies in 
line with TUSLA’s guidance;
d) Prioritising initiatives under 
the new DEIS programme to 
address early school leaving; 
and
e) Providing supports including 
homework clubs, additional 
tuition, career guidance/
counselling support, community 
awareness of drugs programme 
and youth work in collaboration 
with schools and other youth 
programmes/schemes.
DES 
 
 
 
 
DES
HSE
TUSLA
(Joint 
Leads) 
 
TUSLA
 
 
DES
 
 
 
DHPLG
HSE 
 
 
 
 
 
 
 
 
 
 
 
 
DES
 
 
TUSLA
1.2.6 Ensure those 
who do not seem 
to thrive in a 
traditional academic 
setting complete 
their education.
Reviewing Senior Cycle programmes 
and Vocational Pathways in senior 
cycle with a view to recommending 
areas for development.
DES
1.2.7 Facilitate increased 
use of school 
buildings, where 
feasible, for 
afterschool care 
and out of hours 
use to support local 
communities.
Engaging with property owners 
and school authorities to facilitate 
increased use of school buildings, 
where feasible, for afterschool care 
and out of hours use to support 
local communities.
DES
1.2.8 Improve services 
for young people 
at risk of substance 
misuse in socially 
and economically 
disadvantaged 
communities.
Developing a new scheme to 
provide targeted, appropriate and 
effective services for young people 
at risk of substance misuse, focused 
on socially and economically 
disadvantaged communities.
DOH DCYA, HSE, 
DATF.
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No. Strategic Action Delivered by: Lead 
Agency
Partners
1.3.9 Mitigate the risk 
and reduce the 
impact of parental 
substance misuse 
on babies and 
young children.
a) Developing and adopting 
evidence-based family and 
parenting skills programmes 
for services engaging with 
high risk families impacted by 
problematic substance use;
b) Building awareness of the 
hidden harm of parental 
substance misuse with the aim 
of increasing responsiveness to 
affected children;
c) Developing protocols between 
addiction services, maternity 
services and children’s health 
and social care services that will 
facilitate a coordinated response 
to the needs of children affected 
by parental substance misuse; 
and
d) Ensuring adult substance use 
services identify clients who 
have dependent children and 
contribute actively to meeting 
their needs either directly or 
through referral to or liaison 
with other appropriate services, 
including those in the non-
statutory sector.
HSE, 
TUSLA
(Joint 
Leads)
NFSN
C&V sectors
1.3.10 Strengthen the 
life-skills of young 
people leaving 
care in order to 
reduce their risk 
of developing 
substance use 
problems.
Considering how best to provide 
necessary once-off supports for 
Care Leavers to gain practical life-
long skills in line with Action 69 of 
the Ryan Report in order to reduce 
their risk of developing substance 
use problems.
TUSLA
1.3.11 Strengthen early 
harm reduction 
responses to 
current and 
emerging trends 
and patterns of 
drug use.
Establishing a working group to 
examine the evidence in relation 
to early harm reduction responses, 
such as drug testing, amnesty bins 
and media campaigns, to current 
and emerging trends including the 
use of new psychoactive substances 
and image and performance 
enhancing drugs and other high risk 
behaviours, including chemsex.
HSE DOH
2.1.12 Strengthen the 
implementation of 
the National Drugs 
Rehabilitation 
Framework.
a) Developing a competency 
framework on key working, care 
planning and case management; 
and
b) Extending the training 
programme on the key 
processes of the National Drugs 
Rehabilitation Framework.
HSE
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.13 Expand the 
availability and 
geographical 
spread of relevant 
quality drug and 
alcohol services and 
improve the range 
of services available, 
based on identified 
need.
a) Identifying and addressing gaps 
in provision within Tier 1, 2, 3 
and 4 services;
b) Increasing the number of 
treatment episodes provided 
across the range of services 
available, including:
l  Low Threshold;
l  Stabilisation;
l  Detoxification;
l  Rehabilitation;
l  Step-down;
l  After-Care;
c) Strengthening the capacity of 
services to address complex 
needs.
HSE C&V sectors, 
DATFs
2.1.14 Improve the 
availability of 
Opioid Substitution 
Treatments (OSTs).
Examining potential mechanisms to 
increase access to OSTs such as the 
expansion of GP prescribing, nurse-
led prescribing and the provision of 
OSTs in community-based settings 
and homeless services.
HSE DOH
2.1.15 Enhance the quality 
and safety of care 
in the delivery of 
Opioid Substitution 
Treatment (OST).
Implementing the HSE National 
Clinical Guidelines on OST and 
reviewing in line with National 
Clinical Effectiveness Committee 
processes.
HSE DOH
2.1.16 Improve relapse 
prevention and 
aftercare services.
Developing and broadening the 
range of peer-led, mutual aid and 
family support programmes in 
accordance with best practice.
HSE C&V sectors, 
UISCE, NFSN
2.1.17 Further strengthen 
services to support 
families affected by 
substance misuse.
a) Developing addiction specific 
bereavement support 
programmes and support 
the provision of respite for 
family members;
b) Supporting families with 
non-violent resistance training 
to address child to parent 
violence; and
c) Supporting those caring for 
children/young people in their 
family as a result of substance 
misuse to access relevant 
information, supports and 
services.
TUSLA HSE, NFSN
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Partners
2.1.18 Help individuals 
affected by 
substance misuse to 
build their recovery 
capital.
a) Monitoring and supporting 
the implementation of 
the Department of Social 
Protection’s Programme 
Framework for Community 
Employment Drug 
Rehabilitation Schemes, based 
on an integrated inter-agency 
approach; and
b) Utilising SICAP to improve the 
life chances and opportunities 
of those who are marginalised 
in society, living in poverty 
or in unemployment through 
community development 
approaches, targeted supports 
and interagency collaboration.
DSP
 
 
 
 
 
 
 
 
DHPLG
HSE
Other 
relevant 
Departments 
& Agencies, 
C&V sectors
2.1.19 Increase the range 
of progression 
options for 
recovering drug 
users and develop a 
new programme of 
supported care and 
employment.
Establishing a Working Group to:
a) Examine the range of 
progression options for 
those exiting treatment, prison, 
Community Employment 
schemes including key skills 
training and community 
participation with a view to 
developing a new programme 
of supported care and 
employment; and
b) Identify and remedy the 
barriers to accessing the 
range of educational, personal 
development, training and 
employment opportunities 
and supports, including gender 
specific barriers and the lack 
of childcare provision, for 
those in recovery.
DOH HSE, DSP, 
IPS, Other 
relevant 
Departments 
& Agencies
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No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.20 Expand addiction 
services for 
pregnant and 
postnatal women.
a) Strenghtening links between 
maternity services and addiction 
services;
b) Quantifying the need 
for additional residential 
placements for pregnant and 
postnatal women who need in-
patient treatment for addiction 
to drugs and/or alcohol across 
the country;
c) Developing services to meet 
that need ensuring that 
such facilities support the 
development of the mother-
baby relationship;
d) Providing dedicated support 
for pregnant women with 
alcohol dependency, including 
examining the need to expand 
the role of the Drug Liaison 
Midwife (DLM) in this regard. 
Any such expansion will likely 
generate a need to further 
increase the number of such 
midwives;
e) Resourcing the National Women 
and Infants Health Programme 
(NWIHP) to provide drug liaison 
midwives and specialist medical 
social workers in all maternity 
networks;
f) Supporting maternity hospitals/
units to strengthen their 
methods of detecting alcohol 
abuse and supporting women to 
reduce their intake; and
g) Engaging the NWIHP to 
develop a consistent approach 
to informing women about the 
risks of alcohol consumption 
during pregnancy.
DOH HSE
2.1.21 Respond to the 
needs of women 
who are using drugs 
and/or alcohol in a 
harmful manner.
a) Increasing the range of wrap-
around community and 
residential services equipped to 
meet the needs of women who 
are using drugs and/or alcohol 
in a harmful manner, including 
those with children and those 
who are pregnant; and
b) Developing interventions to 
address gender and cultural 
specific risk factors for not 
taking up treatment.
HSE DOH, DATFs
87Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
No. Strategic Action Delivered by: Lead 
Agency
Partners
2.1.22 Expand the range, 
availability and 
geographical 
spread of problem 
drug and alcohol 
services for those 
under the age of 18.
a) Identifying and addressing gaps 
in child and adolescent service 
provision;
b) Developing multi-disciplinary 
child and adolescent teams; and
c) Developing better interagency 
cooperation between problem 
substance use and child and 
family services.
HSE, 
TUSLA
C&V sectors, 
DATFs
2.1.23 Improve the 
response to the 
needs of older 
people with long 
term substance use 
issues.
Examining the need for the 
development of specialist services 
to meet the needs of older people 
with long term substance use issues.
HSE C&V sectors, 
DATFs
2.1.24 Improve outcomes 
for people with 
co-morbid severe 
mental illness and 
substance misuse 
problems.
a) Supporting the new Mental 
Health Clinical Programme to 
address dual diagnosis; and
b) Developing joint protocols 
between mental health 
services and drug and alcohol 
services with the objective of 
undertaking an assessment 
with integrated care planning 
in line with the National Drug 
Rehabilitation Framework.
HSE DOH, IPS, 
C&V sectors
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Agency
Partners
2.1.25 In line with 
Rebuilding Ireland, 
improve the 
range of problem 
substance use 
services and 
rehabilitation 
supports for people 
with high support 
needs who are 
homeless.
a) Increasing the number of 
detoxification, stabilisation and 
rehabilitation beds;
b) Providing additional/enhanced 
assessment, key working, care 
planning and case management. 
This entails person-centred 
holistic care planning, including 
identifying and building social 
and recovery capital;
c) Ensuring in-reach support 
during treatment and 
rehabilitation to prevent 
homelessness on discharge 
to ensure that housing and 
supports are in place;
d) Ensuring resourcing and 
enhanced cooperation 
arrangements between non-
governmental service providers 
and State organisations, 
involved in the delivery of 
addiction treatment and 
housing services, so that the 
drug rehabilitation pathway is 
linked to sustainable supported 
housing-led/housing first 
tenancy arrangements; and
e) Developing the provision of 
gender and culturally specific 
step down services, particularly 
housing, for women and 
their children progressing 
from residential rehabilitation 
treatment who are at risk of 
discharge into homelessness.
HSE 
 
HSE 
 
 
 
 
 
HSE 
 
 
 
 
DOH
DHPLG 
 
 
 
 
 
 
 
 
 
 
LAs, HSE
C&V sectors 
 
LAs, C&V 
sectors
 
 
 
 
 
LAs, C&V 
sectors
 
 
 
 
HSE, LAs, 
C&V sectors 
 
 
 
 
 
 
 
 
 
DHPLG, DOH, 
C&V sectors
2.1.26 Intervene early 
with at risk groups 
in criminal justice 
settings.
a) Providing training to enable 
the delivery of screening, brief 
intervention and onward referral 
in line with national screening 
and brief intervention protocols 
for problem substance use;
b) Further develop the range 
of service specific problem 
substance use interventions 
in line with best international 
practice; and
c) Determining the prevalence 
of NPS use in prison settings 
with a view to developing 
specific training for staff and 
appropriate interventions.
IPS, PS 
 
 
 
 
IPS, PS 
 
 
 
IPS
AGS, HSE 
 
 
 
 
 
 
 
 
HSE
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2.1.27 Improve the 
capacity of services 
to accommodate 
the needs of 
people who use 
drugs and alcohol 
from specific 
communities 
including 
the Traveller 
community; 
the lesbian, 
gay, bisexual, 
transgender and 
intersex community; 
new communities; 
sex workers and 
homeless people.
a) Fostering engagement with 
representatives of these 
communities, and/or services 
working with them, as 
appropriate;
b) Considering the need for 
specialist referral pathways for 
specific groups who may not 
otherwise attend traditional 
addiction services (i.e. those 
who engage in chemsex);
c) Providing anti-racism, cultural 
competency and equality 
training to service providers; 
and
d) Ensuring all services engage 
in ethnic equality monitoring 
by reporting on the nationality, 
ethnicity and cultural 
background of service users for 
the NDTRS and treat related 
disclosures with sensitivity.
HSE C&V sectors
2.2.28 Continue to expand 
Harm Reduction 
Initiatives focused 
on people who 
inject drugs.
a) Expanding needle exchange 
programmes;
b) Increasing the availability 
of screening and treatment 
for blood borne viruses and 
communicable diseases; and
c) Increasing the uptake of 
Hepatitis C treatment.
HSE C&V sectors
2.2.29 Provide enhanced 
clinical support to 
people who inject 
drugs and mitigate 
the issue of public 
injecting.
Establishing a pilot supervised 
injecting facility and evaluating 
the effectiveness of the initiative.
HSE DOH, UISCE, 
Dublin City 
Council, 
Relevant 
Local 
Authorities, 
C&V sectors
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2.2.30 Continue to target 
a reduction in drug-
related deaths and 
non-fatal overdoses.
a) Finalising HSE-led Overdose 
Prevention Strategy with 
a particular focus on 
implementing preventative 
measures to target high-risk 
cohorts of the drug-using 
population and known overdose 
risk periods;
b) Expanding the availability of 
Naloxone to people who use 
drugs, their peers, and family 
members;
c) Developing synergies between 
Reducing Harm, Supporting 
Recovery and other relevant 
strategies and frameworks 
in particular “Connecting for 
Life” whose primary aim is 
to reduce suicide rates in the 
whole population and amongst 
specified priority groups; and
d) Providing suicide prevention 
training to staff working with 
young people in the area of 
alcohol and substance use, in 
line with Connecting for Life.
HSE 
 
 
 
 
 
 
HSE 
 
 
DOH 
 
 
 
 
 
 
 
HSE
DOH 
 
 
 
 
 
 
C&V sectors, 
UISCE, NFSN, 
DATFs
 
 
 
 
 
 
 
 
 
HSE
DOH
3.1.31 Keep legislation up-
to-date to deal with 
emerging trends in 
the drugs situation.
Keep legislation under review, 
against the background of national, 
EU and broader international 
experiences and best practice, 
to deal with emerging trends, 
including:
a) new synthetic substances;
b) new or changed uses of 
psychoactive substances; and
c) the evolving situation with 
regard to drug precursors and 
the surface web and dark net 
drug markets.
DOH, DJE AGS, 
Revenue’s 
Customs 
Service, 
HPRA
3.1.32 Reduce rates of 
driving under the 
influence of drugs.
Implementing the measures relating 
to the testing of drivers for drugs 
and alcohol contained in the Road 
Traffic Act 2016.
DTTAS
3.1.33 Reduce drug 
offending behaviour 
and promote 
rehabilitation.
Implementing the recommendations 
of the Final Report of the Working 
Group on a Strategic Review of 
Penal Policy of July 2014 relating to 
drug-offending behaviours.
DJE
3.1.34 Map the future 
direction and 
objectives of the 
Drug Treatment 
Court.
a) Carrying out an independent 
evaluation of the Drug 
Treatment Court; and
b) Continuing to support the 
operation of the Drug Treatment 
Court, having regard to the 
recommendations made in the 
2013 review 53, pending the 
outcome of the evaluation.
DJE
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3.1.35 Consider the 
approaches taken in 
other jurisdictions 
to the possession 
of small quantities 
of drugs for 
personal use with 
a view to making 
recommendations 
on policy options to 
the relevant Minister 
within 12 months.
Establishing a Working Group to 
consider the approaches taken in 
other jurisdictions to the possession 
of small quantities of drugs for 
personal use in light of the Report 
of the Joint Committee on Justice, 
Defence and Equality on a Harm 
Reducing and Rehabilitative 
approach to possession of small 
amounts of illegal drugs to examine:
a) the current legislative 
regime that applies to simple 
possession offences in this 
jurisdiction and the rationale 
underpinning this approach, 
and any evidence of its 
effectiveness;
b) the approaches and experiences 
in other jurisdictions to dealing 
with simple possession offences;
c) the advantages and 
disadvantages, as well as the 
potential impact and outcomes 
of any alternative approaches 
to the current system for the 
individual, the family and 
society, as well as for the 
criminal justice system and the 
health system;
d) the identification of the scope 
of any legislative changes 
necessary to introduce 
alternative options to criminal 
sanctions for those offences;
e) a cost benefit analysis of 
alternative approaches to 
criminal sanctions for simple 
possession offences; and
f) make recommendations to the 
relevant Minister within twelve 
months.
DOH, DJE
(Joint)
AGS, Relevant
Departments 
and agencies
3.2.36 Support the role of 
law enforcement 
authorities in 
monitoring 
drug markets, in 
particular new drug 
markets, surface 
web and darknet 
drug markets.
Investing in capacity building 
measures to support the role 
of law enforcement authorities 
in monitoring drug markets, in 
particular new drug markets, surface 
web and darknet drug markets.
AGS, 
Revenue 
Custom’s 
Service
DOH, DJE, 
HPRA
3.2.37 Consider the case 
for the use of 
Community Impact 
Statements within 
the Criminal Justice 
System in Ireland.
Subject to the completion of the 
Garda examination of Community 
Impact Statements, bringing 
forward recommendations on their 
implementation.
AGS
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3.3.38 Strengthen the 
response to the 
illegal drug market, 
including the 
changing nature of 
new psychoactive 
substances.
a) Continuing to develop systems 
to monitor changing drug 
trends in line with the EU Early 
Warning System; 
b) Completing the development 
of the HSE public alert system 
for adverse events due to 
drugs and commencing 
implementation;
c) Supporting government 
funded laboratories, tasked 
with analysis of drugs of abuse, 
to engage in novel analytical 
development work, in relation 
to psychoactive drugs but 
especially new psychoactive 
substances (licit or illicit), while 
continuing to fulfil their core 
functions;
d) Providing funding in the capital 
expenditure programme for the 
construction of a purpose built 
new laboratory for Forensic 
Science Ireland with €6m 
prioritised to commence the 
project immediately; and
e) Strengthen the legal robustness 
of Presumptive Drug Testing 
(PDT) to contribute to the 
timely prosecution of Section 
(3) drug-related offences.
DOH 
 
 
 
HSE 
 
 
 
DPER, 
DTTAS 
 
 
 
 
 
 
 
DJE
HSE, HRB, 
FSI, State 
Lab, MBRS
AGS 
DOH, HSE, 
DJE
4.1.39 Support and 
promote 
community 
participation in all 
local, regional and 
national structures.
Supporting and promoting 
community participation in all local, 
regional and national structures.
DOH Community 
Sector, LAs, 
DHPLG, 
DATFs
4.1.40 Measure the 
impact of drug-
related crime 
and wider public 
nuisance issues on 
communities.
Developing and piloting a 
Community Impact Assessment Tool 
in order to measure the impact of 
drug-related crime and wider public 
nuisance issues on communities.
C&V 
sectors
4.1.41 Enhance the 
relationship 
between an Garda 
Síochána and 
local communities 
in relation to the 
impact of the drugs 
trade.
Building on the achievements of 
Local Policing Fora in providing an 
effective mechanism for building 
and maintaining relationships 
between an Garda Síochána and the 
local communities, in particular in 
relation to the impact of the drugs 
trade.
DJE, 
DHPLG, 
AGS
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No. Strategic Action Delivered by: Lead 
Agency
Partners
4.1.42 Strengthen the 
effectiveness of 
the Drug-Related 
Intimidation 
Reporting 
Programme.
An Garda Síochána and the National 
Family Support Network will each 
carry out its own evaluation of the 
Drug-Related Intimidation Reporting 
Programme to strengthen its 
effectiveness and, if appropriate, 
develop measures to raise public 
awareness of the programme.
AGS, 
NFSN
4.2.43 Build capacity 
within drug and 
alcohol services to 
develop a patient 
safety approach 
in line with the 
HIQA National 
Standards for Safer 
Better Healthcare.
Requiring the delivery of services 
within a Quality Assurance 
Framework, which will
a) standardise services;
b) include basic tools in relation 
to safety, complaints, 
competencies and procedures 
around prescribing; and
c) reflect a human rights based 
and person centred approach.
DOH HSE
4.2.44 Promote the 
participation of 
service users and 
their families, 
including those 
in recovery, in 
local, regional and 
national decision-
making structures 
and networks in 
order to facilitate 
their involvement in 
the design, planning 
and development 
of services and 
policies.
Actively supporting frontline 
services through capacity building 
measures using evidence based 
models of participation in line with 
best practice.
DOH Relevant 
Departments 
and Agencies, 
C&V sectors, 
DATFs, 
Networks of 
people who 
use drugs 
and alcohol, 
Networks of 
people who 
use services 
and/Family 
Support 
Networks
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No. Strategic Action Delivered by: Lead 
Agency
Partners
5.1.45 Strengthen Ireland’s 
drug monitoring 
system.
a) Continuing to monitor the 
drug situation and responses 
for national and international 
purposes using EMCDDA 
protocols and existing data 
collection systems, while 
ensuring that Ireland can 
respond to new data monitoring 
requests arising from the 
National Committee and the 
European Union during the term 
of the Strategy;
b) Separating the organisation and 
budgeting of routine monitoring 
from research projects;
c) Requesting all remaining 
hospital emergency 
departments include the 
monitoring of attendances as 
a result of alcohol and drugs 
use in their electronic patient 
system; and
d) Developing a suitably integrated 
IT system which allows for the 
effective sharing and collection 
of appropriate outcome data.
HRB 
 
 
 
 
 
 
 
 
 
 
DOH 
 
DOH 
 
 
 
 
 
HSE
DOH, HSE, 
HRB
5.1.46 Support evidence-
informed practice 
and service 
provision.
a) Ensuring that public funding is 
targeted at underlying need and 
supports the use of evidence-
informed interventions and the 
evaluation of pilot initiatives;
b) Designating the Health Research 
Board as a central information 
hub on evidence on the drugs 
situation and responses to it;
c) Ensuring that mechanisms are 
in place to communicate this 
evidence in a timely manner 
to those working in relevant 
healthcare settings, including in 
acute and emergency care; and
d) Developing collaborative 
relationships with third level 
institutions in the area of drugs 
and alcohol so as to further 
government funded research 
priorities.
DOH DES, DSP, 
DCYA, HSE, 
IPS, PS, HRB
5.1.47 Strengthen 
the National 
Drug Treatment 
Reporting System 
(NDTRS).
Requiring all publicly funded drug 
and alcohol services to complete 
the NDTRS for all people who use 
services.
DOH, DJE HSE, IPS, C&V 
sectors
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No. Strategic Action Delivered by: Lead 
Agency
Partners
5.1.48 Develop a 
prioritised 
programme of drug 
and alcohol-related 
research on an 
annual basis.
Harnessing existing data sources in 
the drug and alcohol field in order 
to enhance service delivery and 
inform policy and planning across 
government and the community and 
voluntary sectors, and having done 
so, identify deficits in research in the 
field to enable the development of a 
prioritised programme on an annual 
basis.
DOH HSE, HRB
5.1.49 Improve knowledge 
of rehabilitation 
outcomes.
Undertaking a study on 
rehabilitation outcomes, which 
takes into account the experience 
of service users and their families, 
and examines their outcomes across 
multiple domains, building on work 
already undertaken.
DOH, 
HRB
(joint)
HSE, UISCE, 
NFSN, C&V 
sectors
96 Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
No. Strategic Action Delivered by: Lead 
Agency
Partners
6.1.50 Develop an 
implementation 
plan to 
operationalise 
a Performance 
Measurement 
System by 2020 
which will support 
Reducing Harm, 
Supporting 
Recovery, improve 
accountability 
across the statutory, 
community and 
voluntary sectors 
and strengthen the 
Drug and Alcohol 
Task Force model, 
in consultation 
with relevant 
stakeholders and 
sectors.
a) Phasing in the introduction 
of a resource allocation 
model (RAM) to achieve a 
more equitable distribution 
of resources across Task 
Force areas. This will involve 
monitoring and assessing the 
evidence from the operation of 
the RAM on an annual basis;
b) Identifying where significant 
changes in problem drug or 
alcohol use are found from one 
year to the next, or differences 
are observed between areas, 
and analysing why such 
differences have emerged 
with a view to successfully 
implementing the strategy and 
assisting DATFs improve their 
actions and interventions over 
time;
c) Improving the alignment of Task 
Force boundaries;
d) Ensuring that Task Forces have 
appropriate arrangements in 
place for the selection and 
renewal of the Chair and 
members of the Task Force 
and have proper procedures in 
place for addressing conflict of 
interest;
e) Building the capacity of 
DATFs to participate in the 
Performance Measurement 
System; and
f) Coordinating a cross-
Departmental approach at 
national and local level to 
allow for the gathering of 
the appropriate information 
and data streams to feed 
into the ongoing organic 
further development of the 
Performance Measurement 
Framework.
DOH HSE
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APPENDIX 1 – Membership of the Steering 
Committee on the National Drugs Strategy
Sector Body Number of 
Representatives
Statutory Sector Department of Health 3
Statutory Sector Health Service Executive 2
Statutory Sector Department of Justice & Equality 1
Statutory Sector An Garda Síochána 1
Statutory Sector Department of Education & Skills 1
Statutory Sector Department of Housing, Planning 
and Local Government
1
Statutory Sector Department of Children & Youth Affairs 1
Statutory Sector Department of Social Protection 1
Statutory Sector Health Research Board 1
Community Sector Community Sector – represented by CityWide 
Drugs Crisis Campaign
2
Community Sector National Family Support Network 1
Voluntary Sector Voluntary Sector – represented by the 
Voluntary Drug Treatment Network
2
Cross-sector Task Force 
network
Local Drug and Alcohol Task Force Chairs 
Network
1
Cross-sector Task Force 
network
Regional Drug and Alcohol Task Force Chairs 
Network
1
Cross-sector committee National Advisory Committee on Drugs and 
Alcohol
1
Representative group UISCE 1
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APPENDIX 2 – List of relevant inter-
connected strategies and policies
l National Substance Misuse Strategy, 2012
l “Creating a better future together”: National Maternity Strategy 2016-2026
l Healthy Ireland – a framework for improved Health and Wellbeing, 2013-2025
l Better Outcomes, Brighter Futures, 2014-2020
l Updated National Action Plan for Social Inclusion, 2015-2017
l National Sexual Health Strategy 2015-2020
l Connecting for Life: Ireland’s National Strategy to Reduce Suicide 2015-2020
l National Traveller and Roma Inclusion Strategy (2016-2020)
l National Women’s Strategy 2017-2020
l Rebuilding Ireland – action plan for housing and homelessness
l Homeless Strategy National Implementation Plan
l Mental Health Strategy A Vision for Change
l The Joint Irish Prison Service and Probation Service Strategic Plan 2015-2017
l Irish Prison Service 2011, Health Care Standards
l An Garda Síochána’s 2016 National, Regional and Divisional Policing Plans
l Garda Síochána 2017 Crime Prevention and Reduction Strategy
l Garda Síochána Strategy Statement 2016-2018
l An Garda Síochána’s Modernisation and Renewal Programme 2016-2021
l Tobacco Free Ireland, 2013 and Tobacco Free Ireland Action Plan, 2014-2025
l Irish Sports Council’s National Anti-Doping Programme
l EU Drugs Strategy and action plans, 2013-2020
99Reducing Harm, Supporting Recovery A health-led response to drug and alcohol use in Ireland 2017-2025
Glossary of Terms
AA Alcoholics Anonymous
CAMHS Child and Adolescent Mental Health Service
CE Community Employment scheme
CIS Community Impact Statements
CBT Cognitive Behavioural Therapy
DTF Drugs Task Forces
DATF Drug and Alcohol Task Forces
DEIS “Delivering Equality of Opportunity in Schools” programme
DES Department of Education and Skills
DHPLG Department of Housing, Planning and Local Government
DSP Department of Social Protection
DTTAS Department of Transport, Tourism and Sport
DOH Department of Health
DJE Department of Justice and Equality
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
ESRI Economic and Social Research Institute
ESPAD European School Survey Project on Alcohol and Other Drugs
EU European Union
FSI Forensic Science Ireland
GNDOCB Garda National Drugs and Organised Crime Bureau
GP General Practitioner
HBSC Health Behaviour in School-Aged Children survey
HIQA Health Information and Quality Authority
HPSC Health Protection Surveillance Centre
HRB Health Research Board
HSE Health Service Executive
HCV Hepatitis C Virus
ICP Integrated Care Pathway
IPED Image and Performance Enhancing Drugs
IPS Irish Prison Service
LDATF Local Drug and Alcohol Task Force
LDTF Local Drugs Task Force
LGBTI Lesbian, Gay, Bisexual, Transgender and Intersex
LCDC Local Community Development Committee
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MAT Mandatory Alcohol Testing
MIT Mandatory Intoxication Testing
MBRS Medical Bureau of Road Safety
NACDA National Advisory Committee on Drugs and Alcohol
NACD National Advisory Committee on Drugs
NCC National Coordinating Committee for Drugs and Alcohol Task Forces
NDRDI National Drug-Related Deaths Index
NDRF National Drugs Rehabilitation Framework
NDRIC National Drug Rehabilitation Implementation Committee
NDTRS National Drug Treatment Reporting System
NFSN National Family Support Network
NPS New Psychoactive Substance
NWIHP National Women & Infants Health Programme
OFD Oversight Forum on Drugs
OST Opioid Substitution Treatment
PPN Public Participation Network
PWID People who inject drugs
RDATF Regional Drug and Alcohol Task Force
RAM Resource Allocation Model
RDTF Regional Drugs Task Force
SIF Supervised Injecting Facilities
SICAP Social Inclusion and Community Activation Programme
SPHE Social, Personal and Health Education
SWOT Strength, Weakness, Opportunities and Threats analysis
TILDA The Irish Longitudinal Study on Ageing
TUSLA TUSLA Child and Family agency
UN United Nations
UNGASS United Nations General Assembly Special Session (on drugs)
VFMPR Value for Money Policy Review
YoDA Youth Drug and Alcohol Service
YPFSF Young People’s Facilities and Services Fund
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